Profile image
Professor

Professor Miles Davenport

Infection Analytics Program
Phone
9385 2762
E-mail
mdavenport@kirby.unsw.edu.au
Location
Room 519, Kirby Institute, Wallace Wurth Building
Wagstaffe HR; Thwaites RS; Reynaldi A; Sidhu JK; McKendry R; Ascough S; Papargyris L; Collins AM; Xu J; Lemm NM; Siggins MK; Chain BM; Killingley B; Kalinova M; Mann A; Catchpole A; Davenport MP; Openshaw PJM; Chiu C, 2024, 'Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults', Science Immunology, 9, http://dx.doi.org/10.1126/sciimmunol.adj9285
2024
Watson NB; Patel RK; Kean C; Veazey J; Oyesola OO; Laniewski N; Grenier JK; Wang J; Tabilas C; Yee Mon KJ; McNairn AJ; Peng SA; Wesnak SP; Nzingha K; Davenport MP; Tait Wojno ED; Scheible KM; Smith NL; Grimson A; Rudd BD, 2024, 'The gene regulatory basis of bystander activation in CD8+ T cells', Science Immunology, 9, http://dx.doi.org/10.1126/sciimmunol.adf8776
2024
Purcell RA; Aurelia LC; Esterbauer R; Allen LF; Bond KA; Williamson DA; Trevillyan JM; Trubiano JA; Juno JJ; Wheatley AK; Davenport MP; Nguyen THO; Kedzierska K; Kent SJ; Selva KJ; Chung AW, 2024, 'Immunoglobulin G genetic variation can confound assessment of antibody levels via altered binding to detection reagents', Clinical and Translational Immunology, 13, http://dx.doi.org/10.1002/cti2.1494
2024
Underwood AP; Gupta M; Wu BR; Eltahla AA; Boo I; Wang JJ; Agapiou D; Abayasingam A; Reynaldi A; Keoshkerian E; Zhao Y; Brasher N; Walker MR; Bukh J; Maher L; Gordon T; Davenport MP; Luciani F; Drummer HE; Lloyd AR; Bull RA, 2024, 'B-cell characteristics define HCV reinfection outcome', Journal of Hepatology, 81, pp. 415 - 428, http://dx.doi.org/10.1016/j.jhep.2024.04.004
2024
Elias KM; Khan SR; Stadler E; Schlub TE; Cromer D; Polizzotto MN; Kent SJ; Turner T; Davenport MP; Khoury DS, 2024, 'Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: a systematic review and meta-analysis', The Lancet Microbe, 5, pp. e459 - e467, http://dx.doi.org/10.1016/S2666-5247(23)00398-1
2024
Keele BF; Okoye AA; Fennessey CM; Varco-Merth B; Immonen TT; Kose E; Conchas A; Pinkevych M; Lipkey L; Newman L; MacAiran A; Bosche M; Bosche WJ; Berkemeier B; Fast R; Hull M; Oswald K; Shoemaker R; Silipino L; Gorelick RJ; Duell D; Marenco A; Brantley W; Smedley J; Axthelm M; Davenport MP; Lifson JD; Picker LJ, 2024, 'Early antiretroviral therapy in SIV-infected rhesus macaques reveals a multiphasic, saturable dynamic accumulation of the rebound competent viral reservoir', PLoS Pathogens, 20, http://dx.doi.org/10.1371/journal.ppat.1012135
2024
Berry MT; Khan SR; Schlub TE; Notaras A; Kunasekaran M; Grulich AE; MacIntyre CR; Davenport MP; Khoury DS, 2024, 'Predicting vaccine effectiveness for mpox', Nature Communications, 15, pp. 3856, http://dx.doi.org/10.1038/s41467-024-48180-w
2024
Hastak P; Cromer D; Malycha J; Andersen CR; Raith E; Davenport MP; Plummer M; Sasson SC, 2024, 'Defining the correlates of lymphopenia and independent predictors of poor clinical outcome in adults hospitalized with COVID-19 in Australia', Scientific Reports, 14, http://dx.doi.org/10.1038/s41598-024-61729-5
2024
Lee WS; Audsley J; Trieu MC; Reynaldi A; Aurelia LC; Mehta PH; Patterson J; Kent HE; Nguyen J; Amarasena T; Esterbauer R; Haycroft ER; Ramanathan P; Davenport MP; Schlub TE; Sasadeusz J; Wheatley AK; Chung AW; Juno JA; Selva KJ; Kent SJ, 2024, 'Randomized controlled trial reveals no benefit to a 3-month delay in COVID-19 mRNA booster vaccine', Journal of Clinical Investigation, 134, http://dx.doi.org/10.1172/JCI181244
2024
Varco-Merth B; Chaunzwa M; Duell DM; Marenco A; Goodwin W; Dannay R; Nekorchuk M; Shao D; Busman-Sahay K; Fennessey CM; Silipino L; Hull M; Bosche WJ; Fast R; Oswald K; Shoemaker R; Bochart R; MacAllister R; Labriola CS; Smedley JV; Axthelm MK; Davenport MP; Edlefsen PT; Estes JD; Keele BF; Lifson JD; Lewin SR; Picker LJ; Okoye AA, 2024, 'Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistence', PLoS Pathogens, 20, http://dx.doi.org/10.1371/journal.ppat.1012496
2024
Kent SJ; Li S; Amarasena TH; Reynaldi A; Lee WS; Leeming MG; O’Connor DH; Nguyen J; Kent HE; Caruso F; Juno JA; Wheatley AK; Davenport MP; Ju Y, 2024, 'Blood Distribution of SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine in Humans', ACS Nano, 18, pp. 27077 - 27089, http://dx.doi.org/10.1021/acsnano.4c11652
2024
Cromer D; Reynaldi A; Mitchell A; Schlub TE; Juno JA; Wheatley AK; Kent SJ; Khoury DS; Davenport MP, 2024, 'Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updates', Nature Communications, 15, http://dx.doi.org/10.1038/s41467-024-52194-9
2024
Habel JR; Chua BY; Kedzierski L; Selva KJ; Damelang T; Haycroft ER; Nguyen THO; Koay HF; Nicholson S; McQuilten HA; Jia X; Allen LF; Hensen L; Zhang W; van de Sandt CE; Neil JA; Pragastis K; Lau JSY; Jumarang J; Allen EK; Amanant F; Krammer F; Wragg KM; Juno JA; Wheatley AK; Tan HX; Pell G; Walker S; Audsley J; Reynaldi A; Thevarajan I; Denholm JT; Subbarao K; Davenport MP; Hogarth PM; Godfrey DI; Cheng AC; Tong SYC; Bond K; Williamson DA; McMahon JH; Thomas PG; Pannaraj PS; James F; Holmes NE; Smibert OC; Trubiano JA; Gordon CL; Chung AW; Whitehead CL; Kent SJ; Lappas M; Rowntree LC; Kedzierska K, 2023, 'Immune profiling of SARS-CoV-2 infection during pregnancy reveals NK cell and γδ T cell perturbations', JCI Insight, 8, http://dx.doi.org/10.1172/jci.insight.167157
2023
Koutsakos M; Reynaldi A; Lee WS; Nguyen J; Amarasena T; Taiaroa G; Kinsella P; Liew KC; Tran T; Kent HE; Tan HX; Rowntree LC; Nguyen THO; Thomas PG; Kedzierska K; Petersen J; Rossjohn J; Williamson DA; Khoury D; Davenport MP; Kent SJ; Wheatley AK; Juno JA, 2023, 'SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses', Immunity, 56, pp. 879 - 892.e4, http://dx.doi.org/10.1016/j.immuni.2023.02.017
2023
Cromer D; Steain M; Reynaldi A; Schlub TE; Khan SR; Sasson SC; Kent SJ; Khoury DS; Davenport MP, 2023, 'Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis', Nature Communications, 14, pp. 1633, http://dx.doi.org/10.1038/s41467-023-37176-7
2023
Khoury DS; Docken SS; Subbarao K; Kent SJ; Davenport MP; Cromer D, 2023, 'Predicting the efficacy of variant-modified COVID-19 vaccine boosters', Nature Medicine, 29, pp. 574 - 578, http://dx.doi.org/10.1038/s41591-023-02228-4
2023
Khoury DS; Schlub TE; Cromer D; Steain M; Fong Y; Gilbert PB; Subbarao K; Triccas JA; Kent SJ; Davenport MP, 2023, 'Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection', Emerging Infectious Diseases, 29, pp. 381 - 388, http://dx.doi.org/10.3201/eid2902.221422
2023
Underwood AP; Gupta M; Wu B-R; Eltahla AA; Boo I; Wang JJ; Agapiou D; Abayasingam A; Reynaldi A; Keoshkerian E; Zhao Y; Brasher N; Walker MR; Bukh J; Maher L; Gordon T; Davenport M; Luciani F; Drummer HE; Lloyd AR; Bull RA, 2023, 'B Cell Signatures and Antibody Imprinting Define HCV Reinfection Outcome', , http://dx.doi.org/10.2139/ssrn.4418620
2023
Statzu M; Jin W; Fray EJ; Wong AKH; Kumar MR; Ferrer E; Docken SS; Pinkevych M; McBrien JB; Fennessey CM; Keele BF; Liang S; Harper JL; Mutascio S; Franchitti L; Wang H; Cicetti D; Bosinger SE; Carnathan DG; Vanderford TH; Margolis DM; Garcia-Martinez JV; Chahroudi A; Paiardini M; Siliciano J; Davenport MP; Kulpa DA; Siliciano RS; Silvestri G, 2023, 'CD8+ lymphocytes do not impact SIV reservoir establishment under ART', Nature Microbiology, 8, pp. 299 - 308, http://dx.doi.org/10.1038/s41564-022-01311-9
2023
Stadler E; Cromer D; Ogunlade S; Ongoiba A; Doumbo S; Kayentao K; Traore B; Crompton PD; Portugal S; Davenport MP; Khoury DS, 2023, 'Evidence for exposure dependent carriage of malaria parasites across the dry season: modelling analysis of longitudinal data', Malaria Journal, 22, http://dx.doi.org/10.1186/s12936-023-04461-1
2023
Zhang W; Kedzierski L; Chua BY; Mayo M; Lonzi C; Rigas V; Middleton BF; McQuilten HA; Rowntree LC; Allen LF; Purcell RA; Tan HX; Petersen J; Chaurasia P; Mordant F; Pogorelyy MV; Minervina AA; Crawford JC; Perkins GB; Zhang E; Gras S; Clemens EB; Juno JA; Audsley J; Khoury DS; Holmes NE; Thevarajan I; Subbarao K; Krammer F; Cheng AC; Davenport MP; Grubor-Bauk B; Coates PT; Christensen B; Thomas PG; Wheatley AK; Kent SJ; Rossjohn J; Chung AW; Boffa J; Miller A; Lynar S; Nelson J; Nguyen THO; Davies J; Kedzierska K, 2023, 'Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities', Nature Immunology, 24, pp. 966 - 978, http://dx.doi.org/10.1038/s41590-023-01508-y
2023
Bauer A; Lindemuth E; Marino FE; Krause R; Joy J; Docken SS; Mallick S; McCormick K; Holt C; Georgiev I; Felber B; Keele BF; Veazey R; Davenport MP; Li H; Shaw GM; Bar KJ, 2023, 'Adaptation of a transmitted/founder simian-human immunodeficiency virus for enhanced replication in rhesus macaques', PLoS Pathogens, 19, http://dx.doi.org/10.1371/journal.ppat.1011059
2023
Lansink LIM; Skinner OP; Engel JA; Lee HJ; Soon MSF; Williams CG; SheelaNair A; Pernold CPS; Laohamonthonkul P; Akter J; Stoll T; Hill MM; Talman AM; Russell A; Lawniczak M; Jia X; Chua B; Anderson D; Creek DJ; Davenport MP; Khoury DS; Haque A, 2023, 'Systemic host inflammation induces stage-specific transcriptomic modification and slower maturation in malaria parasites', mBio, 14, pp. e0112923, http://dx.doi.org/10.1128/mbio.01129-23
2023
Lee WS; Tan HX; Reynaldi A; Esterbauer R; Koutsakos M; Nguyen J; Amarasena T; Kent HE; Aggarwal A; Turville SG; Taiaroa G; Kinsella P; Liew KC; Tran T; Williamson DA; Cromer D; Davenport MP; Kent SJ; Juno JA; Khoury DS; Wheatley AK, 2023, 'Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection', Science Advances, 9, http://dx.doi.org/10.1126/sciadv.adg5301
2023
Stadler E; Burgess MT; Schlub TE; Khan SR; Chai KL; McQuilten ZK; Wood EM; Polizzotto MN; Kent SJ; Cromer D; Davenport MP; Khoury DS, 2023, 'Monoclonal antibody levels and protection from COVID-19', Nature Communications, 14, pp. 4545, http://dx.doi.org/10.1038/s41467-023-40204-1
2023
Selva KJ; Ramanathan P; Haycroft ER; Tan CW; Wang LF; Downie LE; Davis SK; Purcell RA; Kent HE; Juno JA; Wheatley AK; Davenport MP; Kent SJ; Chung AW, 2023, 'Mucosal antibody responses following Vaxzevria vaccination', Immunology and Cell Biology, 101, pp. 975 - 983, http://dx.doi.org/10.1111/imcb.12685
2023
Selva KJ; Ramanathan P; Haycroft ER; Reynaldi A; Cromer D; Tan CW; Wang LF; Wines BD; Hogarth PM; Downie LE; Davis SK; Purcell RA; Kent HE; Juno JA; Wheatley AK; Davenport MP; Kent SJ; Chung AW, 2023, 'Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections', JCI Insight, 8, http://dx.doi.org/10.1172/jci.insight.172470
2023
Pinkevych M; Docken SS; Okoye AA; Fennessey CM; Del Prete GQ; Pino M; Harper JL; Betts MR; Paiardini M; Keele BF; Davenport MP, 2023, 'Timing of initiation of anti-retroviral therapy predicts post-treatment control of SIV replication', PLoS Pathogens, 19, http://dx.doi.org/10.1371/journal.ppat.1011660
2023
Stadler E; Chai KL; Schlub TE; Cromer D; Khan SR; Polizzotto MN; Kent SJ; Beecher C; White H; Turner T; Skoetz N; Estcourt L; McQuilten ZK; Wood EM; Khoury DS; Davenport MP, 2023, 'Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis', The Lancet Microbe, 4, pp. e883 - e892, http://dx.doi.org/10.1016/S2666-5247(23)00194-5
2023
Docken SS; McCormick K; Pampena MB; Samer S; Lindemuth E; Pinkevych M; Viox EG; Wu Y; Schlub TE; Cromer D; Keele BF; Paiardini M; Betts MR; Bar KJ; Davenport MP, 2023, 'Preferential selection of viral escape mutants by CD8+ T cell 'sieving' of SIV reactivation from latency', PLoS Pathogens, 19, http://dx.doi.org/10.1371/journal.ppat.1011755
2023
Cele S; Jackson L; Khoury DS; Khan K; Moyo-Gwete T; Tegally H; San JE; Cromer D; Scheepers C; Amoako DG; Karim F; Bernstein M; Lustig G; Archary D; Smith M; Ganga Y; Jule Z; Reedoy K; Hwa SH; Giandhari J; Blackburn JM; Gosnell BI; Abdool Karim SS; Hanekom W; Davies MA; Hsiao M; Martin D; Mlisana K; Wibmer CK; Williamson C; York D; Harrichandparsad R; Herbst K; Jeena P; Khoza T; Kløverpris H; Leslie A; Madansein R; Magula N; Manickchund N; Marakalala M; Mazibuko M; Moshabela M; Mthabela N; Naidoo K; Ndhlovu Z; Ndung’u T; Ngcobo N; Nyamande K; Patel V; Smit T; Steyn A; Wong E; von Gottberg A; Bhiman JN; Lessells RJ; Moosa MYS; Davenport MP; de Oliveira T; Moore PL; Sigal A, 2022, 'Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization', Nature, 602, pp. 654 - 656, http://dx.doi.org/10.1038/s41586-021-04387-1
2022
Wragg KM; Lee WS; Koutsakos M; Tan HX; Amarasena T; Reynaldi A; Gare G; Konstandopoulos P; Field KR; Esterbauer R; Kent HE; Davenport MP; Wheatley AK; Kent SJ; Juno JA, 2022, 'Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory', Nature Immunology, 23, pp. 768 - 780, http://dx.doi.org/10.1038/s41590-022-01175-5
2022
SheelaNair A; Romanczuk AS; Aogo RA; Haldar RN; Lansink LIM; Cromer D; Salinas YG; Guy RK; McCarthy JS; Davenport MP; Haque A; Khoury DS, 2022, 'Similarly efficacious anti-malarial drugs SJ733 and pyronaridine differ in their ability to remove circulating parasites in mice', Malaria Journal, 21, http://dx.doi.org/10.1186/s12936-022-04075-z
2022
Cromer D; Reynaldi A; Steain M; Triccas JA; Davenport MP; Khoury DS, 2022, 'Relating in Vitro Neutralization Level and Protection in the CVnCoV (CUREVAC) Trial', Clinical Infectious Diseases, 75, pp. E878 - E879, http://dx.doi.org/10.1093/cid/ciac075
2022
Kent SJ; Khoury DS; Reynaldi A; Juno JA; Wheatley AK; Stadler E; John Wherry E; Triccas J; Sasson SC; Cromer D; Davenport MP, 2022, 'Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?', Nature Reviews Immunology, 22, pp. 387 - 397, http://dx.doi.org/10.1038/s41577-022-00716-1
2022
Cromer D; Steain M; Reynaldi A; Schlub TE; Wheatley AK; Juno JA; Kent SJ; Triccas JA; Khoury DS; Davenport MP, 2022, 'Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis', The Lancet Microbe, 3, pp. e52 - e61, http://dx.doi.org/10.1016/S2666-5247(21)00267-6
2022
Stern J; Solomon A; Dantanarayana A; Pascoe R; Reynaldi A; Davenport MP; Milush J; Deeks SG; Hartogensis W; Hecht FM; Cockerham L; Roche M; Lewin SR, 2022, 'Cell-Associated Human Immunodeficiency Virus (HIV) Ribonucleic Acid Has a Circadian Cycle in Males With HIV on Antiretroviral Therapy', Journal of Infectious Diseases, 225, pp. 1721 - 1730, http://dx.doi.org/10.1093/infdis/jiab533
2022
Aggarwal A; Stella AO; Walker G; Akerman A; Esneau C; Milogiannakis V; Burnett DL; McAllery S; Silva MR; Lu Y; Foster CSP; Brilot F; Pillay A; Van Hal S; Mathivanan V; Fichter C; Kindinger A; Hoppe AC; Munier ML; Amatayakul-Chantler S; Roth N; Coppola G; Symonds GP; Schofield P; Jackson J; Lenthall H; Henry JY; Mazigi O; Jäck HM; Davenport MP; Darley DR; Matthews GV; Khoury DS; Cromer D; Goodnow CC; Christ D; Robosa R; Starck DJ; Bartlett NW; Rawlinson WD; Kelleher AD; Turville SG, 2022, 'Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia', Nature Microbiology, 7, pp. 896 - 908, http://dx.doi.org/10.1038/s41564-022-01135-7
2022
Goel RR; Painter MM; Lundgreen KA; Apostolidis SA; Baxter AE; Giles JR; Mathew D; Pattekar A; Reynaldi A; Khoury DS; Gouma S; Hicks P; Dysinger S; Hicks A; Sharma H; Herring S; Korte S; KC W; Oldridge DA; Erickson RI; Weirick ME; McAllister CM; Awofolaju M; Tanenbaum N; Dougherty J; Long S; D'Andrea K; Hamilton JT; McLaughlin M; Williams JC; Adamski S; Kuthuru O; Drapeau EM; Davenport MP; Hensley SE; Bates P; Greenplate AR; Wherry EJ, 2022, 'Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine', Cell, 185, pp. 1875 - 1887.e8, http://dx.doi.org/10.1016/j.cell.2022.04.009
2022
Koutsakos M; Lee WS; Reynaldi A; Tan HX; Gare G; Kinsella P; Liew KC; Taiaroa G; Williamson DA; Kent HE; Stadler E; Cromer D; Khoury DS; Wheatley AK; Juno JA; Davenport MP; Kent SJ, 2022, 'The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants', Immunity, 55, pp. 1316 - 1326.e4, http://dx.doi.org/10.1016/j.immuni.2022.05.018
2022
Tan HX; Davenport MP; Kent SJ; Wheatley AK, 2022, 'Nice and slow make the germinal centers go: measured and escalating antigen delivery enhance durability and quality of humoral immune responses against HIV-1', Immunology and Cell Biology, 100, pp. 750 - 752, http://dx.doi.org/10.1111/imcb.12596
2022
Stadler E; Cromer D; Mehra S; Adekunle AI; Flegg JA; Anstey NM; Watson JA; Chu CS; Mueller I; Robinson LJ; Schlub TE; Davenport MP; Khoury DS, 2022, 'Population heterogeneity in Plasmodium vivax relapse risk', PLoS Neglected Tropical Diseases, 16, http://dx.doi.org/10.1371/journal.pntd.0010990
2022
Habel JR; Chua BY; Kedzierski L; Selva KJ; Damelang T; Haycroft ER; Nguyen THO; Koay H-F; Nicholson S; McQuilten H; Jia X; Allen LF; Hensen L; Zhang W; van de Sandt CE; Neil JA; Amanant F; Krammer F; Wragg K; Juno JA; Wheatley AK; Tan H-X; Pell G; Audsley J; Reynaldi A; Thevarajan I; Denholm J; Subbarao K; Davenport MP; Hogarth M; Godrey DI; Cheng AC; Tong SYC; Bond K; Williamson DA; James F; Holmes NE; Smibert OC; Trubiano JA; Gordon CL; Chung AW; Whitehead C; Kent SJ; Lappas M; Rowntree LC; Kedzierska K, 2022, 'Integrated immune networks in SARS-CoV-2 infected pregnant women reveal differential NK cell and unconventional T cell activation', The Journal of Immunology, 208, pp. 125.10 - 125.10, http://dx.doi.org/10.4049/jimmunol.208.supp.125.10
2022
Tabilas C; Iu DS; Daly CWP; Yee Mon KJ; Reynaldi A; Wesnak SP; Grenier JK; Davenport MP; Smith NL; Grimson A; Rudd BD, 2022, 'Early microbial exposure shapes adult immunity by altering CD8+ T cell development', Proceedings of the National Academy of Sciences of the United States of America, 119, http://dx.doi.org/10.1073/pnas.2212548119
2022
Radohery GFR; Walz A; Gumpp C; Cherkaoui-Rbati MH; Gobeau N; Gower J; Davenport MP; Rottmann M; McCarthy JS; Möhrle JJ; Rebelo M; Demarta-Gatsi C; Khoury DS, 2022, 'Parasite Viability as a Measure of in Vivo Drug Activity in Preclinical and Early Clinical Antimalarial Drug Assessment', Antimicrobial Agents and Chemotherapy, 66, http://dx.doi.org/10.1128/aac.00114-22
2022
Radohery GFR; Gower J; Barber BE; Kansagra K; Möhrle JJ; Davenport MP; McCarthy JS; Khoury DS; Rebelo M, 2022, 'Effect of novel antimalarial ZY-19489 on Plasmodium falciparum viability in a volunteer infection study', The Lancet Infectious Diseases, 22, pp. 760 - 761, http://dx.doi.org/10.1016/S1473-3099(22)00294-8
2022
Goel RR; Painter MM; Apostolidis SA; Mathew D; Meng W; Rosenfeld AM; Lundgreen KA; Reynaldi A; Khoury DS; Pattekar A; Gouma S; Kuri-Cervantes L; Hicks P; Dysinger S; Hicks A; Sharma H; Herring S; Korte S; Baxter AE; Oldridge DA; Giles JR; Weirick ME; McAllister CM; Awofolaju M; Tanenbaum N; Drapeau EM; Dougherty J; Long S; D’Andrea K; Hamilton JT; McLaughlin M; Williams JC; Adamski S; Kuthuru O; Frank I; Betts MR; Vella LA; Grifoni A; Weiskopf D; Sette A; Hensley SE; Davenport MP; Bates P; Luning Prak ET; Greenplate AR; John Wherry E, 2021, 'mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern', Science, 374, http://dx.doi.org/10.1126/science.abm0829
2021
Wheatley AK; Pymm P; Esterbauer R; Dietrich MH; Lee WS; Drew D; Kelly HG; Chan LJ; Mordant FL; Black KA; Adair A; Tan HX; Juno JA; Wragg KM; Amarasena T; Lopez E; Selva KJ; Haycroft ER; Cooney JP; Venugopal H; Tan LL; O Neill MT; Allison CC; Cromer D; Davenport MP; Bowen RA; Chung AW; Pellegrini M; Liddament MT; Glukhova A; Subbarao K; Kent SJ; Tham WH, 2021, 'Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain', Cell Reports, 37, http://dx.doi.org/10.1016/j.celrep.2021.109822
2021
Selva KJ; Davis SK; Haycroft ER; Lee WS; Lopez E; Reynaldi A; Davenport MP; Kent HE; Juno JA; Chung AW; Kent SJ, 2021, 'Tear antibodies to SARS-CoV-2: implications for transmission', Clinical and Translational Immunology, 10, http://dx.doi.org/10.1002/cti2.1354
2021
Khoury D; Cromer D; Reynaldi A; Schlub T; Wheatley A; Juno J; Subbarao K; Kent S; Triccas J; Davenport M, 2021, 'What level of neutralising antibody protects from COVID-19?', , http://dx.doi.org/10.1101/2021.03.09.21252641
2021
Khoury DS; Cromer D; Reynaldi A; Schlub TE; Wheatley AK; Juno JA; Subbarao K; Kent SJ; Triccas JA; Davenport MP, 2021, 'Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection', Nature Medicine, 27, pp. 1205 - 1211, http://dx.doi.org/10.1038/s41591-021-01377-8
2021
Wheatley AK; Fox A; Tan HX; Juno JA; Davenport MP; Subbarao K; Kent SJ, 2021, 'Immune imprinting and SARS-CoV-2 vaccine design', Trends in Immunology, 42, pp. 956 - 959, http://dx.doi.org/10.1016/j.it.2021.09.001
2021
Juno J; Wragg K; Lee WS; Amarasena T; Reynaldi A; Koutsakos M; Konstandopoulos P; Field K; Esterbauer R; Tan H-X; Kent H; Davenport M; Wheatley A; Kent S, 2021, 'Tracking the kinetics and phenotype of spike epitope-specific CD4 T cell immunity in the context of SARS-CoV-2 infection and vaccination', , http://dx.doi.org/10.21203/rs.3.rs-957030/v1
2021
Pymm P; Adair A; Chan LJ; Cooney JP; Mordant FL; Allison CC; Lopez E; Haycroft ER; O'Neill MT; Tan LL; Dietrich MH; Drew D; Doerflinger M; Dengler MA; Scott NE; Wheatley AK; Gherardin NA; Venugopal H; Cromer D; Davenport MP; Pickering R; Godfrey DI; Purcell DFJ; Kent SJ; Chung AW; Subbarao K; Pellegrini M; Glukhova A; Tham WH, 2021, 'Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice', Proceedings of the National Academy of Sciences of the United States of America, 118, http://dx.doi.org/10.1073/pnas.2101918118
2021
Rebelo M; Pawliw R; Gower J; Webb L; Mitchell H; Pava Z; Watts RE; Davenport MP; McCarthy JS; Khoury DS, 2021, 'Parasite Viability as a Superior Measure of Antimalarial Drug Activity in Humans', Journal of Infectious Diseases, 223, pp. 2154 - 2163, http://dx.doi.org/10.1093/infdis/jiaa678
2021
Okoye AA; Duell DD; Fukazawa Y; Varco-Merth B; Marenco A; Behrens H; Chaunzwa M; Selseth AN; Gilbride RM; Shao J; Edlefsen PT; Geleziunas R; Pinkevych M; Davenport MP; Busman-Sahay K; Nekorchuk M; Park H; Smedley J; Axthelm MK; Estes JD; Hansen SG; Keele BF; Lifson JD; Picker LJ, 2021, 'CD8+T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification', Journal of Clinical Investigation, 131, http://dx.doi.org/10.1172/JCI141677
2021
Lee WS; Selva KJ; Davis SK; Wines BD; Reynaldi A; Esterbauer R; Kelly HG; Haycroft ER; Tan HX; Juno JA; Wheatley AK; Hogarth PM; Cromer D; Davenport MP; Chung AW; Kent SJ, 2021, 'Decay of Fc-dependent antibody functions after mild to moderate COVID-19', Cell Reports Medicine, 2, http://dx.doi.org/10.1016/j.xcrm.2021.100296
2021
Wheatley AK; Juno JA; Wang JJ; Selva KJ; Reynaldi A; Tan HX; Lee WS; Wragg KM; Kelly HG; Esterbauer R; Davis SK; Kent HE; Mordant FL; Schlub TE; Gordon DL; Khoury DS; Subbarao K; Cromer D; Gordon TP; Chung AW; Davenport MP; Kent SJ, 2021, 'Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19', Nature Communications, 12, http://dx.doi.org/10.1038/s41467-021-21444-5
2021
Lee WS; Reynaldi A; Amarasena T; Davenport MP; Parsons MS; Kent SJ, 2021, 'Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121', Frontiers in Immunology, 12, http://dx.doi.org/10.3389/fimmu.2021.749891
2021
Cromer D; Juno JA; Khoury D; Reynaldi A; Wheatley AK; Kent SJ; Davenport MP, 2021, 'Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection', Nature Reviews Immunology, 21, pp. 395 - 404, http://dx.doi.org/10.1038/s41577-021-00550-x
2021
Moriarty RV; Golfinos AE; Gellerup DD; Schweigert H; Mathiaparanam J; Balgeman AJ; Weiler AM; Friedrich TC; Keele BF; Davenport MP; Venturi V; OConnor SL, 2021, 'The mucosal barrier and anti-viral immune responses can eliminate portions of the viral population during transmission and early viral growth', PLoS ONE, 16, http://dx.doi.org/10.1371/journal.pone.0260010
2021
Cromer D; Steain M; Reynaldi A; Schlub T; Wheatley A; Juno J; Kent S; Triccas J; Khoury D; Davenport M, 2021, 'SARS-CoV-2 variants: levels of neutralisation required for protective immunity', , http://dx.doi.org/10.1101/2021.08.11.21261876
2021
Selva K; Davis S; Haycroft E; Lee WS; Lopez E; Reynaldi A; Davenport M; Kent H; Juno J; Chung A; Kent S, 2021, 'Tear antibodies to SARS-CoV-2: implications for transmission', , http://dx.doi.org/10.1101/2021.08.02.21261479
2021
Moriarty RV; Fesser N; Sutton MS; Venturi V; Davenport MP; Schlub T; O’Connor SL, 2021, 'Validation of multiplex PCR sequencing assay of SIV', Virology Journal, 18, http://dx.doi.org/10.1186/s12985-020-01473-0
2021
Immonen TT; Fennessey CM; Lipkey L; Thorpe A; Del Prete GQ; Lifson JD; Davenport MP; Keele BF, 2021, 'Transient viral replication during analytical treatment interruptions in SIV infected macaques can alter the rebound-competent viral reservoir', PLoS Pathogens, 17, http://dx.doi.org/10.1371/journal.ppat.1009686
2021
Cromer D; Reynaldi A; Steain M; Triccas J; Davenport M; Khoury D, 2021, 'Relating in vitro neutralisation level and protection in the CVnCoV (CUREVAC) trial', , http://dx.doi.org/10.1101/2021.06.29.21259504
2021
Ju Y; Kelly HG; Dagley LF; Reynaldi A; Schlub TE; Spall SK; Bell CA; Cui J; Mitchell AJ; Lin Z; Wheatley AK; Thurecht KJ; Davenport MP; Webb AI; Caruso F; Kent SJ, 2020, 'Person-specific biomolecular coronas modulate nanoparticle interactions with immune cells in human blood', ACS Nano, 14, pp. 15723 - 15737, http://dx.doi.org/10.1021/acsnano.0c06679
2020
Soon MSF; Lee HJ; Engel JA; Straube J; Thomas BS; Pernold CPS; Clarke LS; Laohamonthonkul P; Haldar RN; Williams CG; Lansink LIM; Moreira ML; Bramhall M; Koufariotis LT; Wood S; Chen X; James KR; Lönnberg T; Lane SW; Belz GT; Engwerda CR; Khoury DS; Davenport MP; Svensson V; Teichmann SA; Haque A, 2020, 'Transcriptome dynamics of CD4+ T cells during malaria maps gradual transit from effector to memory', Nature Immunology, 21, pp. 1597 - 1610, http://dx.doi.org/10.1038/s41590-020-0800-8
2020
Khanal S; Fennessey CM; O'Brien SP; Thorpe A; Reid C; Immonen TT; Smith R; Bess JW; Swanstrom AE; Del Prete GQ; Davenport MP; Okoye AA; Picker LJ; Lifson JD; Keele BF, 2020, 'In vivo validation of the viral barcoding of simian immunodeficiency virus SIVmac239 and the development of new barcoded SIV and subtype B and C simian-human immunodeficiency viruses', Journal of Virology, 94, http://dx.doi.org/10.1128/JVI.01420-19
2020
Immonen TT; Camus C; Reid C; Fennessey CM; Del Prete GQ; Davenport MP; Lifson JD; Keele BF, 2020, 'Genetically barcoded SIV reveals the emergence of escape mutations in multiple viral lineages during immune escape', Proceedings of the National Academy of Sciences of the United States of America, 117, pp. 494 - 502, http://dx.doi.org/10.1073/pnas.1914967117
2020
Vanderven HA; Barr I; Reynaldi A; Wheatley AK; Wines BD; Davenport MP; Hogarth PM; Kent SJ, 2020, 'Fc functional antibody responses to adjuvanted versus unadjuvanted seasonal influenza vaccination in community-dwelling older adults', Vaccine, 38, pp. 2368 - 2377, http://dx.doi.org/10.1016/j.vaccine.2020.01.066
2020
Khoury DS; Zaloumis SG; Grigg MJ; Haque A; Davenport MP; Cromer D; Rebelo M; Cao P; McCaw JM; Simpson JA; Flegg JA; Wilson DW; Anstey NM; McCarthy JS, 2020, 'Malaria Parasite Clearance: What Are We Really Measuring?', Trends in Parasitology, 36, pp. 413 - 426, http://dx.doi.org/10.1016/j.pt.2020.02.005
2020
Davenport MP; Smith NL; Rudd BD, 2020, 'Building a T cell compartment: how immune cell development shapes function', Nature Reviews Immunology, 20, pp. 499 - 506, http://dx.doi.org/10.1038/s41577-020-0332-3
2020
Juno JA; Tan HX; Lee WS; Reynaldi A; Kelly HG; Wragg K; Esterbauer R; Kent HE; Batten CJ; Mordant FL; Gherardin NA; Pymm P; Dietrich MH; Scott NE; Tham WH; Godfrey DI; Subbarao K; Davenport MP; Kent SJ; Wheatley AK, 2020, 'Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19', Nature Medicine, 26, pp. 1428 - 1434, http://dx.doi.org/10.1038/s41591-020-0995-0
2020
Corder RM; de Lima ACP; Khoury DS; Docken SS; Davenport MP; Ferreira MU, 2020, 'Quantifying and preventing plasmodium vivax recurrences in primaquine-untreated pregnant women: An observational and modeling study in Brazil', PLoS Neglected Tropical Diseases, 14, pp. 1 - 16, http://dx.doi.org/10.1371/journal.pntd.0008526
2020
Khoury DS; Cao P; Zaloumis SG; Davenport MP, 2020, 'Artemisinin Resistance and the Unique Selection Pressure of a Short-acting Antimalarial', Trends in Parasitology, 36, pp. 884 - 887, http://dx.doi.org/10.1016/j.pt.2020.07.004
2020
Khoury DS; Wheatley AK; Ramuta MD; Reynaldi A; Cromer D; Subbarao K; O’Connor DH; Kent SJ; Davenport MP, 2020, 'Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models', Nature Reviews Immunology, 20, pp. 727 - 738, http://dx.doi.org/10.1038/s41577-020-00471-1
2020
Smith CJ; Venturi V; Quigley MF; Turula H; Gostick E; Ladell K; Hill BJ; Himelfarb D; Quinn KM; Greenaway HY; Dang THY; Seder RA; Douek DC; Hill AB; Davenport MP; Price DA; Snyder CM, 2020, 'Stochastic expansions maintain the clonal stability of CD8+ T cell populations undergoing memory inflation driven by murine cytomegalovirus', Journal of Immunology, 204, pp. 112 - 121, http://dx.doi.org/10.4049/jimmunol.1900455
2020
Wu Y; Pinkevych M; Xu Z; Keele BF; Davenport MP; Cromer D, 2020, 'Impact of fluctuation in frequency of human immunodeficiency virus/simian immunodeficiency virus reactivation during antiretroviral therapy interruption', Proceedings of the Royal Society B: Biological Sciences, 287, http://dx.doi.org/10.1098/rspb.2020.0354
2020
Deleage C; Immonen TT; Fennessey CM; Reynaldi A; Reid C; Newman L; Lipkey L; Schlub TE; Camus C; O'Brien S; Smedley J; Conway JM; Del Prete GQ; Davenport MP; Lifson JD; Estes JD; Keele BF, 2019, 'Defining early SIV replication and dissemination dynamics following vaginal transmission', Science Advances, 5, pp. eaav7116, http://dx.doi.org/10.1126/sciadv.aav7116
2019
Parsons MS; Lee WS; Kristensen AB; Amarasena T; Khoury G; Wheatley AK; Reynaldi A; Wines BD; Hogarth PM; Davenport MP; Kent SJ, 2019, 'Fc-dependent functions are redundant to efficacy of anti-HIV antibody PGT121 in macaques', Journal of Clinical Investigation, 129, pp. 182 - 191, http://dx.doi.org/10.1172/JCI122466
2019
Reynaldi A; Dent AE; Schlub TE; Ogolla S; Rochford R; Davenport MP, 2019, 'Interaction between maternally derived antibodies and heterogeneity in exposure combined to determine time-to-first Plasmodium falciparum infection in Kenyan infants', Malaria Journal, 18, pp. 19, http://dx.doi.org/10.1186/s12936-019-2657-6
2019
Kent SJ; Davenport MP, 2019, 'Moving the HIV vaccine field forward: concepts of protective immunity', The Lancet HIV, 6, pp. e406 - e410, http://dx.doi.org/10.1016/S2352-3018(19)30134-1
2019
Liu J; Hill BJ; Darko S; Song K; Quigley MF; Asher TE; Morita Y; Greenaway HY; Venturi V; Douek DC; Davenport MP; Price DA; Roederer M, 2019, 'The peripheral differentiation of human natural killer T cells', Immunology and Cell Biology, 97, pp. 586 - 596, http://dx.doi.org/10.1111/imcb.12248
2019
Reynaldi A; Smith NL; Schlub TE; Tabilas C; Venturi V; Rudd BD; Davenport MP, 2019, 'Fate mapping reveals the age structure of the peripheral T cell compartment', Proceedings of the National Academy of Sciences of the United States of America, 116, pp. 3974 - 3981, http://dx.doi.org/10.1073/pnas.1811634116
2019
Davenport MP; Khoury DS; Cromer D; Lewin SR; Kelleher AD; Kent SJ, 2019, 'Functional cure of HIV: the scale of the challenge', Nature Reviews Immunology, 19, pp. 45 - 54, http://dx.doi.org/10.1038/s41577-018-0085-4
2019
Akter J; Khoury DS; Aogo R; Lansink LIM; SheelaNair A; Thomas BS; Laohamonthonkul P; Pernold CPS; Dixon MWA; Soon MSF; Fogg LG; Engel JA; Elliott T; Sebina I; James KR; Cromer D; Davenport MP; Haque A, 2019, 'Plasmodium-specific antibodies block in vivo parasite growth without clearing infected red blood cells', PLoS Pathogens, 15, pp. e1007599, http://dx.doi.org/10.1371/journal.ppat.1007599
2019
Pinkevych M; Fennessey CM; Cromer D; Reid C; Trubey CM; Lifson JD; Keele BF; Davenport MP, 2019, 'Predictors of SIV recrudescence following antiretroviral treatment interruption', eLife, 8, pp. e49022, http://dx.doi.org/10.7554/eLife.49022
2019
Khoury DS; Cromer D; Möhrle JJ; McCarthy JS; Davenport MP, 2019, 'Corrigendum: Defining the effectiveness of antimalarial chemotherapy: Investigation of the lag in parasite clearance following drug administration (Journal of Infectious Diseases (2016) 214 (753-761) DOI: 10.1093/infdis/jiw234)', Journal of Infectious Diseases, 219, pp. 1852 - 1853, http://dx.doi.org/10.1093/infdis/jiy729
2019
Pino M; King C; Shim I; Wang H; Nguyen K; Samer S; Harper J; Lifson J; Reynaldi A; Deleage C; Padhan K; Cervasi B; Davenport MP; Petrovas C; Lederman MM; Paiardini M, 2019, 'Fingolimod treatment at ART initiation delays SIV rebound after ART interruption', Journal of Virus Eradication, 5, pp. 3 - 3, http://dx.doi.org/10.1016/s2055-6640(20)31078-5
2019
Stern J; Roche M; Solomon A; Dantanarayana A; Reynaldi A; Davenport M; Deeks SG; Hartogenesis W; Hecht FM; Cockerham L; Lewin SR, 2019, 'Cell-associated HIV RNA and the ratio of HIV RNA to DNA have circadian cycles in HIV-positive individuals on antiretoviral therapy', Journal of Virus Eradication, 5, pp. 10 - 10, http://dx.doi.org/10.1016/s2055-6640(20)31037-2
2019
Betts M; Kuri Cervantes L; Pampena MB; Samer S; Khoury D; Frank I; Paiardini M; Davenport M; Bar K; Veazey R, 2019, 'Peripheral blood SIV/HIV originates from infected cells in tissues', Journal of Virus Eradication, 5, pp. 27 - 27, http://dx.doi.org/10.1016/s2055-6640(20)30142-4
2019
Charon J; Grigg MJ; Eden JS; Piera KA; Rana H; William T; Rose K; Davenport MP; Anstey NM; Holmes EC, 2019, 'Novel RNA viruses associated with Plasmodium vivax in human malaria and Leucocytozoon parasites in avian disease', PLoS Pathogens, 15, pp. e1008216, http://dx.doi.org/10.1371/journal.ppat.1008216
2019
Aliota MT; Dudley DM; Newman CM; Weger-Lucarelli J; Stewart LM; Koenig MR; Breitbach ME; Weiler AM; Semler MR; Barry GL; Zarbock KR; Haj AK; Moriarty RV; Mohns MS; Mohr EL; Venturi V; Schultz-Darken N; Peterson E; Newton W; Schotzko ML; Simmons HA; Mejia A; Hayes JM; Capuano S; Davenport MP; Friedrich TC; Ebel GD; O’Connor SL; O’Connor DH, 2018, 'Molecularly barcoded Zika virus libraries to probe in vivo evolutionary dynamics', PLoS Pathogens, 14, pp. e1006964, http://dx.doi.org/10.1371/journal.ppat.1006964
2018
Smith NL; Patel RK; Reynaldi A; Grenier JK; Wang J; Watson NB; Nzingha K; Yee Mon KJ; Peng SA; Grimson A; Davenport MP; Rudd BD, 2018, 'Developmental Origin Governs CD8+ T Cell Fate Decisions during Infection', Cell, 174, pp. 117 - 130.e14, http://dx.doi.org/10.1016/j.cell.2018.05.029
2018
Khoury DS; Aogo R; Randriafanomezantsoa-Radohery G; McCaw JM; Simpson JA; McCarthy JS; Haque A; Cromer D; Davenport MP, 2018, 'Within-host modeling of blood-stage malaria', Immunological Reviews, 285, pp. 168 - 193, http://dx.doi.org/10.1111/imr.12697
2018
Smithey MJ; Venturi V; Davenport MP; Buntzman AS; Vincent BG; Frelinger JA; Nikolich-Žugich J, 2018, 'Lifelong CMV infection improves immune defense in old mice by broadening the mobilized TCR repertoire against third-party infection', Proceedings of the National Academy of Sciences of the United States of America, 115, pp. E6817 - E6825, http://dx.doi.org/10.1073/pnas.1719451115
2018
Aogo RA; Khoury DS; Cromer D; Elliott T; Akter J; Fogg LG; Nair AS; Liligeto UN; Soon MSF; Thomas BS; Pernold CPS; Romanczuk AS; Laohamonthonkul P; Haque A; Davenport MP, 2018, 'Quantification of host-mediated parasite clearance during blood-stage Plasmodium infection and anti-malarial drug treatment in mice', International Journal for Parasitology, 48, pp. 903 - 913, http://dx.doi.org/10.1016/j.ijpara.2018.05.010
2018
Zaloumis SG; Cao P; Dini S; Davenport MP; Cromer D; Khoury DS; Fowkes FJI; McCaw JM; Simpson JA, 2018, 'In silico investigation of the decline in clinical efficacy of artemisinin combination therapies due to increasing artemisinin and partner drug resistance', Antimicrobial Agents and Chemotherapy, 62, pp. 10.1128/aac.01292 - 10.1128/aac.01218, http://dx.doi.org/10.1128/AAC.01292-18
2018
Pinkevych M; Fennessey CM; Cromer D; Tolstrup M; Søgaard OS; Rasmussen TA; Keele BF; Davenport MP, 2018, 'Estimating initial viral levels during simian immunodeficiency virus/human immunodeficiency virus reactivation from latency', Journal of Virology, 92, http://dx.doi.org/10.1128/JVI.01667-17
2018
Parsons MS; Cromer D; Davenport MP; Kent SJ, 2018, 'HIV Reactivation after Partial Protection by Neutralizing Antibodies', Trends in Immunology, 39, pp. 359 - 366, http://dx.doi.org/10.1016/j.it.2017.12.006
2018
Vanderven HA; Liu L; Ana-Sosa-Batiz F; Nguyen THO; Wan Y; Wines B; Mark Hogarth P; Tilmanis D; Reynaldi A; Parsons MS; Hurt AC; Davenport MP; Kotsimbos T; Cheng AC; Kedzierska K; Zhang X; Xu J; Kent SJ, 2017, 'Fc functional antibodies in humans with severe H7N9 and seasonal influenza', Journal of Clinical Investigation, 2, pp. e92750, http://dx.doi.org/10.1172/jci.insight.92750
2017
Petravic J; Rasmussen TA; Lewin SR; Kent SJ; Davenport MP, 2017, 'Relationship between measures of HIV reactivation and decline of the latent reservoir under latencyreversing agents', Journal of Virology, 91, pp. 10.1128/jvi.02092 - 10.1128/jvi.02016, http://dx.doi.org/10.1128/JVI.02092-16
2017
Khoury DS; Cromer D; Elliott T; Soon MSF; Thomas BS; James KR; Best SE; Aogo RA; Engel JA; Gartlan KH; Akter J; Sebina I; Haque A; Davenport MP, 2017, 'Characterising the effect of antimalarial drugs on the maturation and clearance of murine blood-stage Plasmodium parasites in vivo', International Journal for Parasitology, 47, pp. 913 - 922, http://dx.doi.org/10.1016/j.ijpara.2017.05.009
2017
Cromer D; Pinkevych M; Rasmussen TA; Lewin SR; Kent SJ; Davenport MP, 2017, 'Modeling of antilatency treatment in HIV: What is the optimal duration of antiretroviral therapy-free HIV remission?', Journal of Virology, 91, pp. 10.1128/jvi.01395 - 10.1128/jvi.01317, http://dx.doi.org/10.1128/JVI.01395-17
2017
Khoury DS; Cromer D; Akter J; Sebina I; Elliott T; Thomas BS; Soon MSF; James KR; Best SE; Haque A; Davenport MP, 2017, 'Host-mediated impairment of parasite maturation during blood-stage Plasmodium infection', Proceedings of the National Academy of Sciences of the United States of America, 114, pp. 7701 - 7706, http://dx.doi.org/10.1073/pnas.1618939114
2017
Fennessey CM; Pinkevych M; Immonen TT; Reynaldi A; Venturi V; Nadella P; Reid C; Newman L; Lipkey L; Oswald K; Bosche WJ; Trivett MT; Ott DE; Estes JD; Del Prete GQ; Lifson JD; Davenport MP; Keele BF, 2017, 'Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy', PLoS Pathogens, 13, pp. e1006359, http://dx.doi.org/10.1371/journal.ppat.1006359
2017
Parsons MS; Lloyd SB; Lee WS; Kristensen AB; Amarasena T; Center RJ; Keele BF; Lifson JD; La Branche CC; Montefiori D; Wine BD; Hogarth PM; Swiderek KM; Venturi V; Davenport MP; Kent SJ, 2017, 'Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection', Science Translational Medicine, 9, http://dx.doi.org/10.1126/scitranslmed.aaf1483
2017
Cao P; Klonis N; Zaloumis S; Khoury DS; Cromer D; Davenport MP; Tilley L; Simpson JA; McCaw JM, 2017, 'A mechanistic model quantifies artemisinin-induced parasite growth retardation in blood-stage Plasmodium falciparum infection', Journal of Theoretical Biology, 430, pp. 117 - 127, http://dx.doi.org/10.1016/j.jtbi.2017.07.017
2017
Lee WS; Kristensen AB; Rasmussen TA; Tolstrup M; Østergaard L; Søgaard OS; Wines BD; Mark Hogarth P; Reynaldi A; Davenport MP; Emery S; Amin J; Cooper DA; Kan VL; Fox J; Gruell H; Parsons MS; Kent SJ, 2017, 'Anti-HIV-1 ADCC antibodies following latency reversal and treatment interruption', Journal of Virology, 91, pp. 10.1128/jvi.00603 - 10.1128/jvi.00617, http://dx.doi.org/10.1128/JVI.00603-17
2017
Lee WS; Kristensen AB; Tolstrup M; Østergaard L; Søgaard OS; Wines BD; Hogarth PM; Reynaldi A; Davenport M; Emery S; Amin J; Cooper DA; Kan V; Fox J; Grüll H; Parsons MS; Kent SJ; Rasmussen TA, 2017, '13 HIV-1-specific ADCC following anti-latency therapy and analytical treatment interruption', Journal of Virus Eradication, 3, pp. 10 - 10, http://dx.doi.org/10.1016/s2055-6640(20)30718-4
2017
Lloyd SB; Niven KP; Kiefel BR; Montefiori DC; Reynaldi A; Davenport MP; Kent SJ; Winnall WR, 2017, 'Exploration of broadly neutralizing antibody fragments produced in bacteria for the control of HIV', Human Vaccines and Immunotherapeutics, 13, pp. 2726 - 2737, http://dx.doi.org/10.1080/21645515.2017.1368935
2017
Younes SA; Freeman ML; Mudd JC; Shive CL; Reynaldi A; Panigrahi S; Estes JD; Deleage C; Lucero C; Anderson J; Schacker TW; Davenport MP; McCune JM; Hunt PW; Lee SA; Serrano-Villar S; Debernardo RL; Jacobson JM; Canaday DH; Sekaly RP; Rodriguez B; Sieg SF; Lederman MM, 2016, 'IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection', Journal of Clinical Investigation, 126, pp. 2745 - 2756, http://dx.doi.org/10.1172/JCI85996
2016
Reynaldi A; Schlub TE; Chelimo K; Sumba PO; Piriou E; Ogolla S; Moormann AM; Rochford R; Davenport MP, 2016, 'Impact of Plasmodium falciparum Coinfection on Longitudinal Epstein-Barr Virus Kinetics in Kenyan Children', Journal of Infectious Diseases, 213, pp. 985 - 991, http://dx.doi.org/10.1093/infdis/jiv525
2016
Reynaldi A; Schlub TE; Piriou E; Ogolla S; Sumba OP; Moormann AM; Rochford R; Davenport MP, 2016, 'Modeling of EBV Infection and Antibody Responses in Kenyan Infants with Different Levels of Malaria Exposure Shows Maternal Antibody Decay is a Major Determinant of Early EBV Infection', Journal of Infectious Diseases, 214, pp. 1390 - 1398, http://dx.doi.org/10.1093/infdis/jiw396
2016
Alinejad-Rokny H; Anwar F; Waters SA; Davenport MP; Ebrahimi D, 2016, 'Source of CpG depletion in the HIV-1 genome', Molecular Biology and Evolution, 33, pp. 3205 - 3212, http://dx.doi.org/10.1093/molbev/msw205
2016
Pinkevych M; Cromer D; Tolstrup M; Grimm AJ; Cooper DA; Lewin SR; Søgaard OS; Rasmussen TA; Kent SJ; Kelleher AD; Davenport MP, 2016, 'Erratum: HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days-Implications for HIV Remission (PLoS Pathogens (2015) 11:7 (e1005000) DOI: 10.1371/journal.ppat.1005000)', PLoS Pathogens, 12, pp. e1005745, http://dx.doi.org/10.1371/journal.ppat.1005745
2016
Venturi V; Nzingha K; Amos TG; Charles WC; Dekhtiarenko I; Cicin-Sain L; Davenport MP; Rudd BD, 2016, 'The neonatal CD8+ T cell repertoire rapidly diversifies during persistent viral infection', Journal of Immunology, 196, pp. 1604 - 1616, http://dx.doi.org/10.4049/jimmunol.1501867
2016
Cromer D; Grimm AJ; Schlub TE; Mak J; Davenport MP, 2016, 'Estimating the in-vivo HIV template switching and recombination rate', AIDS, 30, pp. 185 - 192, http://dx.doi.org/10.1097/QAD.0000000000000936
2016
Reynaldi A; Smith NL; Schlub TE; Venturi V; Rudd BD; Davenport MP, 2016, 'Modeling the dynamics of neonatal CD8+ T-cell responses', Immunology and Cell Biology, 94, pp. 838 - 848, http://dx.doi.org/10.1038/icb.2016.47
2016
, 2016, 'Oral abstracts of the 21st International AIDS Conference 18-22 July 2016, Durban, South Africa.', J Int AIDS Soc, 19, pp. 21264, http://dx.doi.org/10.7448/IAS.19.6.21264
2016
Cromer D; Schlub TE; Smyth RP; Grimm AJ; Chopra A; Mallal S; Davenport MP; Mak J, 2016, 'HIV-1 mutation and recombination rates are different in macrophages and T-cells', Viruses, 8, pp. 118, http://dx.doi.org/10.3390/v8040118
2016
Khoury DS; Cromer D; Möhrle JJ; McCarthy JS; Davenport MP, 2016, 'Defining the effectiveness of antimalarial chemotherapy: Investigation of the lag in parasite clearance following drug administration', Journal of Infectious Diseases, 214, pp. 753 - 761, http://dx.doi.org/10.1093/infdis/jiw234
2016
Pinkevych M; Kent SJ; Tolstrup M; Lewin SR; Cooper DA; Søgaard OS; Rasmussen TA; Kelleher AD; Cromer D; Davenport MP, 2016, 'Modeling of Experimental Data Supports HIV Reactivation from Latency after Treatment Interruption on Average Once Every 5–8 Days', PLoS Pathogens, 12, pp. e1005740, http://dx.doi.org/10.1371/journal.ppat.1005740
2016
Griffin P; Pasay C; Elliott S; Sekuloski S; Sikulu M; Hugo L; Khoury D; Cromer D; Davenport M; Sattabongkot J; Ivinson K; Ockenhouse C; McCarthy J, 2016, 'Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria Transmission', PLoS Neglected Tropical Diseases, 10, pp. e0005139, http://dx.doi.org/10.1371/journal.pntd.0005139
2016
Ortiz AM; Carnathan DG; Yu J; Sheehan KM; Kim P; Reynaldi A; Vanderford TH; Klatt NR; Brenchley JM; Davenport MP; Silvestri G, 2016, 'Analysis of the in vivo turnover of CD4+ T-cell subsets in chronically SIV-infected sooty mangabeys', PLoS ONE, 11, pp. e0156352, http://dx.doi.org/10.1371/journal.pone.0156352
2016
Lloyd SB; Lichtfuss M; Amarasena TH; Alcantara S; De Rose R; Tachedjian G; Alinejad-Rokny H; Venturi V; Davenport MP; Winnall WR; Kent SJ, 2016, 'High fidelity simian immunodeficiency virus reverse transcriptase mutants have impaired replication in vitro and in vivo', Virology, 492, pp. 1 - 10, http://dx.doi.org/10.1016/j.virol.2016.02.008
2016
Adekunle AI; Cromer D; Davenport MP, 2016, 'Artemisinin-based treatments in pregnant women with malaria', New England Journal of Medicine, 375, pp. 283, http://dx.doi.org/10.1056/NEJMc1604709
2016
D'Alessandro U; PREGACT Study Group , 2016, 'Artemisinin-Based Treatments in Pregnant Women with Malaria.', N Engl J Med, 375, pp. 283 - 284, http://dx.doi.org/10.1056/NEJMc1604709
2016
Pinkevych M; Reynaldi A; Fennessey C; Reid C; Nadella P; Lipkey L; Newman L; Ayala V; Jain S; Del Prete G; Estes J; Ott D; Lifson J; Ohlen C; Keele B; Davenport M, 2016, 'OA2-1 Frequent and ‘burst-like’ reactivation from latency in SIVmac239M infected macaques', Journal of Virus Eradication, 2, pp. 2 - 2, http://dx.doi.org/10.1016/s2055-6640(20)31008-6
2016
Pinkevych M; Petravic J; Bereczky S; Rooth I; Färnert A; Davenport MP, 2015, 'Understanding the relationship between plasmodium falciparum growth rate and multiplicity of infection', Journal of Infectious Diseases, 211, pp. 1121 - 1127, http://dx.doi.org/10.1093/infdis/jiu561
2015
Haqqani AA; Marek SL; Kumar J; Davenport M; Wang H; Tilton JC, 2015, 'Central memory CD4+ T cells are preferential targets of double infection by HIV-1 Retroviruses', Virology Journal, 12, pp. 184, http://dx.doi.org/10.1186/s12985-015-0415-0
2015
Liehl P; Meireles P; Albuquerque IS; Pinkevych M; Baptista F; Mota MM; Davenport MP; Prudêncio M, 2015, 'Innate immunity induced by Plasmodium liver infection inhibits malaria reinfections', Infection and Immunity, 83, pp. 1172 - 1180, http://dx.doi.org/10.1128/IAI.02796-14
2015
Waugh C; Cromer D; Grimm A; Chopra A; Mallal S; Davenport M; Mak J, 2015, 'A general method to eliminate laboratory induced recombinants during massive, parallel sequencing of cDNA library', Virology Journal, 12, pp. 55, http://dx.doi.org/10.1186/s12985-015-0280-x
2015
Pinkevych M; Cromer D; Tolstrup M; Grimm AJ; Cooper DA; Lewin SR; Søgaard OS; Rasmussen TA; Kent SJ; Kelleher AD; Davenport MP, 2015, 'HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days—Implications for HIV Remission', PLoS Pathogens, 11, pp. e1005000, http://dx.doi.org/10.1371/journal.ppat.1005000
2015
Khoury DS; Cromer D; Best SE; James KR; Sebina I; Haque A; Davenport MP, 2015, 'Reduced erythrocyte susceptibility and increased host clearance of young parasites slows Plasmodium growth in a murine model of severe malaria', Scientific Reports, 5, pp. 9412, http://dx.doi.org/10.1038/srep09412
2015
Adekunle AI; Pinkevych M; McGready R; Luxemburger C; White LJ; Nosten F; Cromer D; Davenport MP, 2015, 'Modeling the Dynamics of Plasmodium vivax Infection and Hypnozoite Reactivation In Vivo', PLoS Neglected Tropical Diseases, 9, pp. e0003595, http://dx.doi.org/10.1371/journal.pntd.0003595
2015
Tey SK; Davenport MP; Hill GR; Kennedy GA; Durrant ST; Khanna R; Cromer D, 2015, 'Post transplant CMV-specific T-cell immune reconstitution in the absence of global T-cell immunity is associated with a high risk of subsequent virus reactivation', Bone Marrow Transplantation, 50, pp. 315 - 316, http://dx.doi.org/10.1038/bmt.2014.265
2015
Pinkevych M; Chelimo K; Vulule J; Kazura JW; Moormann AM; Davenport MP, 2015, 'Time-to-infection by Plasmodium falciparum is largely determined by random factors', BMC Medicine, 13, pp. 19, http://dx.doi.org/10.1186/s12916-014-0252-9
2015
Martyushev AP; Petravic J; Grimm AJ; Alinejad-Rokny H; Gooneratne SL; Reece JC; Cromer D; Kent SJ; Davenport MP, 2015, 'Epitope-specific CD8+ T cell kinetics rather than viral variability determine the timing of immune escape in simian immunodeficiency virus infection', Journal of Immunology, 194, pp. 4112 - 4121, http://dx.doi.org/10.4049/jimmunol.1400793
2015
Petravic J; Ellenberg P; Chan ML; Paukovics G; Smyth RP; Mak J; Davenport MP, 2014, 'Intracellular dynamics of HIV infection', Journal of Virology, 88, pp. 1113 - 1124, http://dx.doi.org/10.1128/JVI.02038-13
2014
Petravic J; Martyushev A; Reece JC; Kent SJ; Davenport MP, 2014, 'Modeling the timing of antilatency drug administration during HIV treatment', Journal of Virology, 88, pp. 14050 - 14056, http://dx.doi.org/10.1128/JVI.01701-14
2014
Gooneratne SL; Alinejad-Rokny H; Ebrahimi D; Bohn PS; Wiseman RW; O'Connor DH; Davenport MP; Kent SJ, 2014, 'Linking pig-tailed macaque major histocompatibility complex class I haplotypes and cytotoxic T lymphocyte escape mutations in simian immunodeficiency virus infection', Journal of Virology, 88, pp. 14310 - 14325, http://dx.doi.org/10.1128/JVI.02428-14
2014
Smith NL; Wissink E; Wang J; Pinello JF; Davenport MP; Grimson A; Rudd BD, 2014, 'Rapid proliferation and differentiation impairs the development of memory CD8+ T cells in early life', Journal of Immunology, 193, pp. 177 - 184, http://dx.doi.org/10.4049/jimmunol.1400553
2014
Jiang W; Souheil-Antoine Y; Funderburg NT; Mudd JC; Espinosa E; Davenport MP; Babineau DC; Sieg SF; Lederman MM, 2014, 'Cycling memory CD4+ T cells in HIV disease have a diverse T cell receptor repertoire and a phenotype consistent with bystander activation', Journal of Virology, 88, pp. 5369 - 5380, http://dx.doi.org/10.1128/JVI.00017-14
2014
McGary CS; Cervasi B; Chahroudi A; Micci L; Taaffe J; Meeker T; Silvestri G; Davenport MP; Paiardini M, 2014, 'Increased stability and limited proliferation of CD4+ central memory T cells differentiate nonprogressive simian immunodeficiency virus (SIV) infection of sooty mangabeys from progressive SIV infection of rhesus macaques', Journal of Virology, 88, pp. 4533 - 4542, http://dx.doi.org/10.1128/JVI.03515-13
2014
Micci L; Alvarez X; Iriele RI; Ortiz AM; Ryan ES; McGary CS; Deleage C; McAtee BB; He T; Apetrei C; Easley K; Pahwa S; Collman RG; Derdeyn CA; Davenport MP; Estes JD; Silvestri G; Lackner AA; Paiardini M, 2014, 'CD4 Depletion in SIV-Infected Macaques Results in Macrophage and Microglia Infection with Rapid Turnover of Infected Cells', PLoS Pathogens, 10, pp. e1004467, http://dx.doi.org/10.1371/journal.ppat.1004467
2014
Ebrahimi D; Alinejad-Rokny H; Davenport MP; Ebrahimi Mohammadi D, 2014, 'Insights into the motif preference of APOBEC3 enzymes', PLoS ONE, 9, pp. e87679, http://dx.doi.org/10.1371/journal.pone.0087679
2014
Fergusson JR; Smith KE; Fleming VM; Rajoriya N; Newell EW; Simmons R; Marchi E; Björkander S; Kang YH; Swadling L; Kurioka A; Sahgal N; Lockstone H; Baban D; Freeman GJ; Sverremark-Ekström E; Davis MM; Davenport MP; Venturi V; Ussher JE; Willberg CB; Klenerman P, 2014, 'CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages', Cell Reports, 9, pp. 1075 - 1088, http://dx.doi.org/10.1016/j.celrep.2014.09.045
2014
Smyth RP; Schlub TE; Grimm AJ; Waugh C; Ellenberg P; Chopra A; Mallal S; Cromer D; Mak J; Davenport MP, 2014, 'Identifying Recombination Hot Spots in the HIV-1 Genome', Journal of Virology, 88, pp. 2891 - 2902, http://dx.doi.org/10.1128/JVI.03014-13
2014
Schlub TE; Grimm AJ; Smyth RP; Cromer D; Chopra A; Mallal S; Venturi V; Waugh C; Mak J; Davenport MP, 2014, 'Fifteen to twenty percent of HIV substitution mutations are associated with recombination', Journal of Virology, 88, pp. 3837 - 3849, http://dx.doi.org/10.1128/JVI.03136-13
2014
Reece JC; Martyushev A; Petravic J; Grimm A; Gooneratne S; Amaresena T; De Rose R; Loh L; Davenport MP; Kent SJ, 2014, 'Measuring turnover of SIV DNA in resting CD4+ T cells using pyrosequencing: Implications for the timing of HIV eradication therapies', PLoS ONE, 9, pp. e93330, http://dx.doi.org/10.1371/journal.pone.0093330
2014
Hill BJ; Darrah PA; Ende Z; Ambrozak DR; Quinn KM; Darko S; Gostick E; Wooldridge L; Van Den Berg HA; Venturi V; Larsen M; Davenport MP; Seder RA; Price DA; Douek DC, 2014, 'Epitope specificity delimits the functional capabilities of vaccine-induced CD8 T cell populations', Journal of Immunology, 193, pp. 5626 - 5636, http://dx.doi.org/10.4049/jimmunol.1401017
2014
Kent SJ; Davenport MP, 2014, 'Tentative first steps to eradicate latent HIV', The Lancet HIV, 1, pp. e2 - e3, http://dx.doi.org/10.1016/S2352-3018(14)70015-3
2014
Davenport M, 2014, 'A spectrum of (avoidable) HIV latency?', MICROBIOLOGY AUSTRALIA, 35, pp. 95 - 96, http://dx.doi.org/10.1071/MA14029
2014
Micci L; Iriele R; Alvarez X; Ortiz A; Midkiff C; McGary C; Davenport M; Estes J; Lackner A; Silvestri G; Paiardini M, 2014, 'EXPERIMENTAL CD4 DEPLETION PRIOR TO SIV INFECTION IN MACAQUES RESULTS IN ENCEPHALITIS, MASSIVE MACROPHAGES AND MICROGLIA INFECTION, AND RAPID TURNOVER OF INFECTED CELLS', JOURNAL OF MEDICAL PRIMATOLOGY, 43, pp. 380 - 380, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342673700017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Pastori C; Diomede L; Venuti A; Fisher G; Jarvik J; Bomsel M; Sanvito F; Lopalco L, 2014, 'Induction of HIV-blocking anti-CCR5 IgA in Peyers's patches without histopathological alterations.', J Virol, 88, pp. 3623 - 3635, http://dx.doi.org/10.1128/JVI.03663-13
2014
Pinkevych M; Petravic J; Chelimo K; Vulule J; Kazura JW; Moormann AM; Davenport MP, 2014, 'Decreased growth rate of P. falciparum blood stage parasitemia with age in a holoendemic population', Journal of Infectious Diseases, 209, pp. 1136 - 1143, http://dx.doi.org/10.1093/infdis/jit613
2014
Reece JC; Alcantara S; Gooneratne S; Jegaskanda S; Amaresena T; Fernandez CS; Laurie K; Hurt A; O'Connor SL; Harris M; Petravic J; Martyushev A; Grimm A; Davenport MP; Stambas J; De Rose R; Kent SJ, 2013, 'Trivalent live attenuated influenza-simian immunodeficiency virus vaccines: Efficacy and evolution of cytotoxic T lymphocyte escape in macaques', Journal of Virology, 87, pp. 4146 - 4160, http://dx.doi.org/10.1128/JVI.02645-12
2013
Petravic J; Vanderford TH; Silvestri G; Davenport M, 2013, 'Estimating the contribution of the gut to plasma viral load in early SIV infection', Retrovirology, 10, pp. 105, http://dx.doi.org/10.1186/1742-4690-10-105
2013
Jegaskanda S; Amarasena TH; Laurie KL; Tan HX; Butler J; Parsons MS; Alcantara S; Petravic J; Davenport MP; Hurt AC; Reading PC; Kent SJ, 2013, 'Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques', Journal of Virology, 87, pp. 13706 - 13718, http://dx.doi.org/10.1128/JVI.01666-13
2013
Rudd BD; Venturi V; Smith NL; Nzingha K; Goldberg EL; Li G; Nikolich-Zugich J; Davenport MP, 2013, 'Acute Neonatal Infections 'Lock-In' a Suboptimal CD8+ T Cell Repertoire with Impaired Recall Responses', PLoS Pathogens, 9, pp. e1003572, http://dx.doi.org/10.1371/journal.ppat.1003572
2013
Greenaway HY; Ng B; Price D; Douek DC; Davenport MP; Venturi V, 2013, 'NKT and MAIT invariant TCRalpha sequences can be produced efficiently by VJ gene recombination', Immunobiology, 218, pp. 213 - 224, http://dx.doi.org/10.1016/j.imbio.2012.04.003
2013
Khoury DS; Cromer D; Best SE; James KR; Kim PS; Engwerda CR; Haque A; Davenport MP, 2013, 'Effect of mature, blood-stage Plasmodium parasite sequestration on pathogen biomass in mathematical and in vivo models of malaria.', Infection and Immunity, 82, pp. 212 - 220, http://dx.doi.org/10.1128/IAI.00705-13
2013
Tey SK; Kennedy GA; Cromer D; Davenport MP; Walker S; Jones LI; Crough T; Durrant ST; Morton JA; Butler JP; Misra AK; Hill GR; Khanna R, 2013, 'Clinical Assessment of Anti-Viral CD8+ T Cell Immune Monitoring Using QuantiFERON-CMV® Assay to Identify High Risk Allogeneic Hematopoietic Stem Cell Transplant Patients with CMV Infection Complications', PLoS ONE, 8, pp. e74744, http://dx.doi.org/10.1371/journal.pone.0074744
2013
Kent SJ; Reece JC; Petravic J; Martyushev A; Kramski M; De Rose R; Cooper DA; Kelleher AD; Emery S; Cameron PU; Lewin SR; Davenport MP, 2013, 'The search for an HIV cure: Tackling latent infection', The Lancet Infectious Diseases, 13, pp. 614 - 621, http://dx.doi.org/10.1016/S1473-3099(13)70043-4
2013
Pinkevych M; Petravic J; Chelimo K; Vulule J; Kazura JW; Moormann AM; Davenport MP, 2013, 'Density-dependent blood stage Plasmodium falciparum suppresses malaria super-infection in a malaria holoendemic population', American Journal of Tropical Medicine and Hygiene, 89, pp. 850 - 856, http://dx.doi.org/10.4269/ajtmh.13-0049
2013
Venturi V; Rudd BD; Davenport MP, 2013, 'Specificity, promiscuity, and precursor frequency in immunoreceptors', Current Opinion in Immunology, http://dx.doi.org/10.1016/j.coi.2013.07.001
2013
Reece J; Petravic J; Balamurali M; Loh L; Gooneratne S; De Rose R; Kent SJ; Davenport MP, 2013, 'Correction: An “Escape Clock” for Estimating the Turnover of SIV DNA in Resting CD4+ T Cells', PLoS Pathogens, 9, http://dx.doi.org/10.1371/annotation/7556ed6f-2d66-48a9-be38-4aefe4400393
2013
Davenport MP; Dunn-Walters DK, 2013, 'Immunogenetics and transplantation', Current Opinion in Immunology, http://dx.doi.org/10.1016/j.coi.2013.09.001
2013
Venturi V; Rudd BD; Davenport MP, 2013, 'Specificity, promiscuity, and precursor frequency in immunoreceptors', Current Opinion in Immunology, 25, pp. 639 - 645, http://dx.doi.org/10.1016/j.coi.2013.07.001
2013
Davenport MP; Dunn-Walters DK, 2013, 'Immunogenetics and transplantation', Current Opinion in Immunology, 25, pp. 606 - 607, http://dx.doi.org/10.1016/j.coi.2013.09.001
2013
Anwar F; Davenport MP; Ebrahimi Mohammadi D, 2013, 'Footprint of APOBEC3 on the genome of human retroelements', Journal of Virology, 87, pp. 8195 - 8204
2013
Ebrahimi Mohammadi D; Anwar F; Davenport MP, 2012, 'APOBEC3G and APOBEC3F rarely co-mutate the same HIV genome', Retrovirology, 9, pp. 113, http://dx.doi.org/10.1186/1742-4690-9-113
2012
Pinkevych M; Petravic J; Chelimo K; Kazura J; Moormann A; Davenport MP, 2012, 'The Dynamics of Naturally Acquired Immunity to Plasmodium falciparum Infection', PLoS Computational Biology, 8, pp. Article number e1002729, http://dx.doi.org/10.1371/journal.pcbi.1002729
2012
Smyth R; Davenport MP; Mak J, 2012, 'The origins of genetic diversity in HIV-1', Virus Research, 169, pp. 415 - 429, http://dx.doi.org/10.1016/j.virusres.2012.06.015
2012
Valkenburg SA; Venturi V; Dang THY; Bird NL; Doherty PC; Turner SJ; Davenport MP; Kedzierska K, 2012, 'Early priming minimizes the age-related immune compromise of CD8 + T cell diversity and function', PLoS Pathogens, 8, pp. Article number e1002544, http://dx.doi.org/10.1371/journal.ppat.1002544
2012
Kedzierska K; Valkenburg S; Doherty PC; Davenport MP; Venturi V, 2012, 'Use it or lose it: establishment and persistence of T cell memory', Frontiers in Immunology, 3, pp. 1 - 11, http://dx.doi.org/10.3389/fimmu.2012.00357
2012
Venturi V; Davenport MP; Doherty PC; Kedzierska K, 2012, 'Consequences of suboptimal priming are apparent for low-avidity T-cell responses', Immunology and Cell Biology, 90, pp. 216 - 223, http://dx.doi.org/10.1038/icb.2011.36
2012
Smithey MJ; Li G; Venturi V; Davenport MP; Nikolich-Zugich J, 2012, 'Lifelong persistent viral infection alters the naive T cell pool, impairing CD8 T cell immunity in late life', Journal of Immunology, 189, pp. 5356 - 5366, http://dx.doi.org/10.4049/jimmunol.1201867
2012
Valkenburg SA; Venturi V; Dang THY; Bird NL; Doherty PC; Turner SJ; Davenport MP; Kedzierska K, 2012, 'Correction: Early Priming Minimizes the Age-Related Immune Compromise of CD8+T Cell Diversity and Function', PLoS Pathogens, 8, http://dx.doi.org/10.1371/annotation/e142f9de-7f30-4759-bda1-a651e86d5ba6
2012
Plotkin SA; Robinson HL; Davenport MP, 2012, 'Mining the mechanisms of an HIV vaccine.', Nature medicine, 18, pp. 1020 - 1021
2012
Davenport MP, 2012, 'Mining the mechanisms of an HIV vaccine', Nature Medicine, 18, pp. 1020 - 1021, http://dx.doi.org/10.1038/nm.2858
2012
Reece J; Petravic J; Balamurali M; Loh L; De Rose R; Kent SJ; Davenport MP, 2012, 'An “Escape clock” for estimating the turnover of SIV DNA in resting CD4+ T cells', PLoS Pathogens, 8, pp. e1002615, http://dx.doi.org/10.1371/journal.ppat.1002615
2012
Paiardini M; Cervasi B; Reyes-Aviles E; Micci L; Ortiz AM; Chahroudi AM; Vinton C; Gordon SN; Bosinger SE; Francella N; Hallberg PL; Schlub T; Chan ML; Riddick NE; Collman RG; Apetrei C; Pandrea I; Else JG; Munch J; Kirchhoff F; Davenport MP; Brenchley JM; Silvestri G; Cramer EM, 2011, 'Low levels of SIV infection in sooty mangabey central memory CD4 + T cells are associated with limited CCR5 expression', Nature Medicine, 17, pp. 830 - 836, http://dx.doi.org/10.1038/nm.2395
2011
Rudd BD; Venturi V; Li G; Samadder P; Ertelt JM; Way SS; Davenport MP; Nikolich-Zugich J, 2011, 'Nonrandom attrition of the naive CD8+ T-cell pool with aging governed by T-cell receptor: pMHC interactions', Proceedings of the National Academy of Sciences of the United States of America, 108, pp. 13694 - 13699, http://dx.doi.org/10.1073/pnas.1107594108
2011
Schlub TE; Sun JC; Walton SM; Robbins SH; Pinto AK; Munks MW; Hill AB; Brossay L; Oxenius A; Davenport MP, 2011, 'Comparing the kinetics of NK cells, CD4, and CD8 T cells in murine cytomegalovirus infection', Journal of Immunology, 187, pp. 1385 - 1392, http://dx.doi.org/10.4049/jimmunol.1100416
2011
Davenport MP; Schlub T; Sun JC; Walton SM; Robbins SH; Pinto AK; Munks MW; Brossay L; Hill AB; Oxenius A, 2011, 'Comparing the Kinetics of NK Cells, CD4, and CD8 T Cells in Murine Cytomegalovirus Infection', Journal of Immunology, 187, pp. 1385 - 1392, http://dx.doi.org/10.4049/jimmunol.1190037
2011
Petravic J; Davenport MP, 2011, 'Simian-human immunodeficiency infection - is the course set in the acute phase?', PLoS One, 6, pp. e17180 - e17189, http://dx.doi.org/10.1371/journal.pone.0017180
2011
Davenport MP; Ebrahimi Mohammadi D; Anwar F, 2011, 'APOBEC3 Has Not Left an Evolutionary Footprint on the HIV-1 Genome', Journal of Virology, 85, pp. 9139 - 9146, http://jvi.asm.org/content/85/17/9139.full?sid=ca96d928-5132-4714-b693-bde43f5124ed
2011
Rajasuriar R; Booth D; Solomon A; Chua K; Spelman T; Gouillou M; Schlub TE; Davenport MP; Crowe S; Elliott J; Hoy J; Fairley C; Stewart G; Cameron P; Lewin SR, 2010, 'Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of IL 7/IL-7Ra and microbial translocation', Journal of Infectious Diseases, 202, pp. 1254 - 1264
2010
Davenport MP; Petravic J, 2010, 'CD8+ T cell control of HIV-- a known unknown', PLoS Pathogens, 6, pp. e1000728, http://dx.doi.org/10.1371/journal.ppat.1000728
2010
Mrass P; Petravic J; Davenport MP; Weninger W, 2010, 'Cell-autonomous and environmental contributions to the interstitial migration of T cells', Seminars In Immunopathology, 32, pp. 257 - 274
2010
Schlub TE; Badovinac VP; Sabel JT; Harty JT; Davenport MP, 2010, 'Predicting CD62L expression during the CD8+ T-cell response in vivo', Immunology and Cell Biology, 88, pp. 157 - 164
2010
Schlub TE; Smyth RP; Grimm AJ; Mak J; Davenport MP, 2010, 'Accurately measuring recombination between closely related HIV-1 genomes', PLoS Computational Biology, 6, pp. e1000766, http://dx.doi.org/10.1371/journal.pcbi.1000766
2010
Smyth RP; Schlub TE; Grimm A; Venturi V; Chopra A; Mallal S; Davenport MP; Mak J, 2010, 'Reducing chimera formation during PCR amplification to ensure accurate genotyping', Gene, 469, pp. 45 - 51
2010
Rudd BD; Venturi V; Smithey MJ; Way SS; Davenport MP; Nikolich-Zugich J, 2010, 'Diversity of the CD8+ T Cell repertoire elicited against an immunodominant epitope does not depend on the context of infection', Journal of Immunology, 184, pp. 2958 - 2965
2010
Quigley MF; Greenaway HY; Venturi V; Lindsay R; Quinn KM; Seder RA; Douek DC; Davenport MP; Price DA, 2010, 'Convergent recombination shapes the clonotypic landscape of the naïve T-cell repertoire', Proceedings of the National Academy of Sciences of the United States of America, 107, pp. 19414 - 19419, http://dx.doi.org/10.1073/pnas.1010586107
2010
Miles JJ; Bulek AM; Cole DK; Gostick E; Schauenburg AJ; Dolton G; Venturi V; Davenport MP; Tan MP; Burrows SR; Wooldridge L; Price DA; Rizkallah PJ; Sewell AK, 2010, 'Genetic and structural basis for selection of a ubiquitous T cell receptor deployed in Epstein-Barr virus infection', PLoS Pathogens, 6, pp. e1001198, http://dx.doi.org/10.1371/journal.ppat.1001198
2010
Coupland LA; Cromer D; Davenport MP; Parish CR, 2010, 'A novel fluorescent-based assay reveals that thrombopoietin signaling and Bcl-X(L) influence, respectively, platelet and erythrocyte lifespans', Experimental Hematology, 38, pp. 453 - 461
2010
Liang SX; Pinkevych M; Khachigian LM; Parish CR; Davenport MP; Chong BH, 2010, 'Drug-induced thrombocytopenia (DITP): development of a novel NOD/SCID mouse model to evaluate clearance of circulating platelets by drug-dependent antibodies and the efficacy of IVIG', Blood, 116, pp. 1958 - 1960
2010
Reece JC; Loh L; Alcantara S; Fernandez CS; Stambas J; Sexton A; De Rose R; Petravic J; Davenport MP; Kent SJ, 2010, 'Timing of immune escape linked to success or failure of vaccination', PLoS One, 5, pp. 1 - 7, http://dx.doi.org/10.1371/journal.pone.0012774
2010
Yang H; Guimaraes-walker A; Hibbs S; Dong T; Stacey A; Borrow P; Hanke T; Davenport MP; Mcmichael A; Dorrell L, 2009, 'Interleukin-10 responses to therapeutic vaccination during highly active antiretroviral therapy and after analytical therapy interruption', AIDS, 23, pp. 2226 - 2230
2009
Lay MD; Petravic J; Gordon SN; Engram J; Silvestri G; Davenport MP, 2009, 'Is the gut the major source of virus in early simian immunodeficiency virus infection?', Journal of Virology, 83, pp. 7517 - 7523, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2708631/pdf/0552-09.pdf
2009
Davenport MP; Belz GT; Ribeiro RM, 2009, 'The race between infection and immunity: how do pathogens set the pace?', Trends in Immunology, 30, pp. 61 - 66
2009
Price DA; Asher TE; Wilson NA; Nason MC; Brenchley JM; Metzler IS; Venturi V; Gostick E; Chattopadhyay PK; Roederer M; Davenport MP; Watkins DI; Douek DC, 2009, 'Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infection', Journal of Experimental Medicine, 206, pp. 923 - 936, http://dx.doi.org/10.1084/jem.20081127
2009
Loh L; Reece J; Petravic J; Center R; Davenport M; Kent SJ, 2009, 'P09-08. The complexity of the infecting inoculum determines the outcome of infection', Retrovirology, 6, http://dx.doi.org/10.1186/1742-4690-6-S3-P121
2009
Greenaway HY; Kurniawan M; Price DA; Douek DC; Davenport MP; Venturi V, 2009, 'Extraction and characterization of the rhesus macaque T-cell receptor beta-chain genes', Immunology and Cell Biology, 87, pp. 546 - 553
2009
Cukalac T; Moffat JM; Venturi V; Davenport MP; Doherty PC; Turner SJ; Stambas J, 2009, 'Narrowed TCR diversity for immunised mice challenged with recombinant influenza A-HIV Env(311-320) virus.', Vaccine, 27, pp. 6755 - 6761
2009
Kedzierska K; Valkenburg SA; Guillonneau C; Hubert FX; Cukalac T; Curtis JM; Stambas J; Scott HS; Kedzierski L; Venturi V; Davenport MP, 2009, 'Diversity and clonotypic composition of influenza-specific CD8+ TCR repertoires remain unaltered in the absence of Aire', European Journal of Immunology, 40, pp. 849 - 858
2009
Schlub TE; Venturi V; Kedzierska K; Wellard C; Doherty PC; Turner SJ; Ribeiro RM; Hodgkin PD; Davenport MP, 2009, 'Division-linked differentiation can account for CD8+ T-cell phenotype in vivo', European Journal of Immunology, 39, pp. 67 - 77
2009
Cromer D; Stark J; Davenport MP, 2009, 'Low red cell production may protect against severe anemia during a malaria infection--insights from modeling', Journal of Theoretical Biology, 257, pp. 533 - 542
2009
Venturi V; Chin HY; Asher TE; Ladell K; Scheinberg P; Bornstein E; Van Bockel D; Kelleher AD; Douek DC; Price DA; Davenport MP, 2009, 'TCR β-chain sharing in human CD8+ T cell responses to cytomegalovirus and EBV', Journal of Immunology, 181, pp. 7853 - 7862, http://dx.doi.org/10.4049/jimmunol.181.11.7853
2009
Lay MD; Zhang L; Ribeiro RM; Mueller SN; Belz GT; Davenport MP, 2009, 'Kinetics of major histocompatibility class I antigen presentation in acute infection', Journal of Immunology, 182, pp. 902 - 911
2009
Loh L; Reece JC; Fernandez CS; Alcantara S; Center R; Purcell DF; Balamurali M; Petravic J; Davenport MP; Kent SJ; Howard J, 2009, 'Complexity of the inoculum determines the rate of reversion of SIV Gag CD8 T cell mutant virus and outcome of infection', PLoS Pathogens, 5, pp. e1000378, http://dx.doi.org/10.1371/journal.ppat.1000378
2009
Rudd BD; Venturi V; Davenport MP; Smithey M; Alzhanova D; Way SS; Nikolich-Zugich J, 2009, 'Characterization of the diversity of the CD8+ T cell repertoire against the same epitope induced by bacterial or viral immunization (132.9)', The Journal of Immunology, 182, pp. 132.9 - 132.9, http://dx.doi.org/10.4049/jimmunol.182.supp.132.9
2009
Davenport MP; Schlub T; Sabel JL; Harty JT; Badovinac VP, 2009, 'Cell division predicts CD62L expression in vivo (83.6)', The Journal of Immunology, 182, pp. 83.6 - 83.6, http://dx.doi.org/10.4049/jimmunol.182.supp.83.6
2009
Davenport MP; Loh L; Petravic J; Kent SJ, 2008, 'Rates of HIV immune escape and reversion: implications for vaccination', Trends in Microbiology, 16, pp. 561 - 566
2008
Loh L; Petravic J; Batten CJ; Davenport MP; Kent SJ, 2008, 'Vaccination and timing influence SIV immune escape viral dynamics in vivo', PLoS Pathogens, 4, pp. e12, http://dx.doi.org/10.1371/journal.ppat.0040012
2008
Venturi V; Kedzierska K; Tanaka MM; Turner SJ; Doherty PC; Davenport MP, 2008, 'Method for assessing the similarity between subsets of the T cell receptor repertoire', Journal of Immunological Methods, 329, pp. 67 - 80, http://dx.doi.org/10.1016/j.jim.2007.09.016
2008
Kedzierska K; Thomas PG; Venturi V; Davenport MP; Doherty PC; Turner SJ; La Gruta NL, 2008, 'Terminal deoxynucleotidyltransferase is required for the establishment of private virus-specific CD8+ TCR repertoires and facilitates optimal CTL responses', Journal of Immunology, 181, pp. 2556 - 2562
2008
Venturi V; Price DA; Douek DC; Davenport MP, 2008, 'The molecular basis for public T-cell responses?', Nature Reviews Immunology, 8, pp. 231 - 238
2008
Smith MZ; Asher TE; Venturi V; Davenport MP; Douek DC; Price DA; Kent SJ, 2008, 'Limited maintenance of vaccine-induced simian immunodeficiency virus-specific CD8 T-cell receptor clonotypes after virus challenge', Journal of Virology, 82, pp. 7357 - 7368
2008
Venturi V; Chin HY; Price DA; Douek DC; Davenport MP, 2008, 'The Role of Production Frequency in the Sharing of Simian Immunodeficiency Virus-Specific CD8+ TCRs between Macaques', Journal of Immunology, 181, pp. 2597 - 2609
2008
Venturi V; Chin HY; Asher TE; Ladell K; Scheinberg P; Bornstein E; van Bockel D; Kelleher AD; Douek DC; Price DA; Davenport MP, 2008, 'TCR beta-chain sharing in human CD8+ T cell responses to cytomegalovirus and EBV', Journal of Immunology, 181, pp. 7853 - 7862
2008
Petravic J; Ribeiro RM; Casimiro DR; Mattapallil J; Roederer M; Shiver JW; Davenport MP, 2008, 'Estimating the impact of vaccination on acute simian-human immunodeficiency virus/simian immunodeficiency virus infections', Journal of Virology, 82, pp. 11589 - 11598
2008
Kedzierska K; Venturi V; Valkenburg SA; Davenport MP; Turner SJ; Doherty PC, 2008, 'Homogenization of TCR repertoires within secondary CD62Lhigh and CD62Llow virus-specific CD8+ T cell populations', Journal of Immunology, 180, pp. 7938 - 7947
2008
Chavez L; Davenport MP; Shiver JW; Tussey LG; Cox KS; Bachinsky M; Wang F; Huang L; Schleif WA; Davies ME; Tang A; Casimiro DR; Perelson AS; Ribeiro RM, 2008, 'The effect of early versus delayed challenge after vaccination in controlling SHIV 89.6P infection', Virology, 381, pp. 75 - 80
2008
Triccas JA; Davenport MP, 2008, 'Infectious diseases:too little, too late for tuberculosis', Immunology and Cell Biology, 86, pp. 293 - 294
2008
Petravic J; Loh L; Kent SJ; Davenport MP, 2008, 'CD4+ target cell availability determines the dynamics of immune escape and reversion in vivo', Journal of Virology, 82, pp. 4091 - 4101
2008
Melenhorst JJ; Lay MD; Price DA; Adams SD; Barrett AJ; Zeilah J; Sosa E; Hensel NF; Follmann D; Douek DC; Davenport MP, 2008, 'Contribution of TCR-β Locus and HLA to the Shape of the Mature Human Vβ Repertoire', Journal of Immunology, 180, pp. 6484 - 6489
2008
Rudd BD; Brien JD; Davenport MP; Nikolich-Zugich J, 2008, 'Cutting edge: TLR ligands increase TCR triggering by slowing peptide-MHC class I decay rates', Journal of Immunology, 181, pp. 5199 - 5203
2008
Loh L; Batten CJ; Petravic J; Davenport MP; Kent SJ, 2007, 'In vivo fitness costs of different Gag CD8 T-cell escape mutant simian-human immunodeficiency viruses for macaques', Journal of Virology, 81, pp. 5418 - 5422
2007
Crough T; Fazou C; Weiss J; Campbell S; Davenport MP; Bell SC; Galbraith A; McNeil K; Khanna R, 2007, 'Symptomatic and asymptomatic viral recrudescence in solid-organ transplant recipients and its relationship with the antigen-specific CD8(+) T-cell response', Journal of Virology, 81, pp. 11538 - 11542
2007
Davenport MP; Price DA; Mcmichael AJ, 2007, 'The T cell repertoire in infection and vaccination: implications for control of persistent viruses', Current Opinion in Immunology, 19, pp. 294 - 300
2007
Karlsson AC; Iversen AKN; Chapman JM; de Oliveira T; Spotts G; McMichael AJ; Davenport MP; Hecht FM; Nixon DF, 2007, 'Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape', PLoS ONE, 2, pp. e225, http://dx.doi.org/10.1371/journal.pone.0000225
2007
Fernandez CS; Smith MZ; Batten CJ; De Rose R; Reece JC; Rollman E; Venturi V; Davenport MP; Kent SJ, 2007, 'Vaccine-induced T cells control reversion of AIDS virus immune escape mutants', Journal of Virology, 81, pp. 4137 - 4144
2007
Venturi V; Kedzierska K; Turner SJ; Doherty PC; Davenport MP, 2007, 'Methods for comparing the diversity of samples of the T cell receptor repertoire', Journal of Immunological Methods, 321, pp. 182 - 195
2007
De Rose R; Batten CJ; Smith MZ; Fernandez CS; Peut V; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Venturi V; Davenport MP; Kent SJ, 2007, 'Comparative efficacy of subtype AE simian-human immunodeficiency virus priming and boosting vaccines in pigtail macaques', Journal of Virology, 81, pp. 292 - 300
2007
van Bockel D; Price DA; Asher TE; Venturi V; Suzuki K; Warton K; Davenport MP; Cooper DA; Douek DC; Kelleher AD, 2007, 'Validation of RNA-based molecular clonotype analysis for virus-specific CD8+ T-cells in formaldehyde-fixed specimens isolated from peripheral blood', Journal of Immunological Methods, 326, pp. 127 - 138, http://dx.doi.org/10.1016/j.jim.2007.07.016
2007
Davenport MP; Ribeiro RM; Zhang L; Wilson DP; Perelson AS, 2007, 'Understanding the mechanisms and limitations of immune control of HIV', Immunological Reviews, 216, pp. 164 - 175
2007
Wilson DP; Mattapallil JJ; Lay MD; Zhang L; Roederer M; Davenport MP, 2007, 'Estimating the infectivity of CCR5-tropic simian immunodeficiency virus SIV(mac251) in the gut', Journal of Virology, 81, pp. 8025 - 8029
2007
Belz GT; Zhang L; Lay M; Kupresanin F; Davenport MP, 2007, 'Killer T cells regulate antigen presentation for early expansion of memory, but not naive, CD8+ T cell', Proceedings of the National Academy of Sciences of the United States of America, 104, pp. 6341 - 6346
2007
Venturi V; Chin H; Asher T; Ladell K; Scheinberg P; Bornstein E; Van Bockel DJ; Kelleher AD; Douek DC; Price DA; Davenport MP, 2007, 'T cell receptor b-chain sharing in human CD8+ T cell responses to cytomegalovirus and Epstein-Barr virus', Journal of Immunology, 181, pp. 7853 - 7862
2007
Orr Y; Wilson DP; Taylor JM; Bannon PG; Geczy C; Davenport MP; Kritharides L, 2007, 'A kinetic model of bone marrow neutrophil production that characterizes late phenotypic maturation', American Journal of Physiology - Regulatory Integrative and Comparative Physiology, 292, pp. R1707 - R1716
2007
La Gruta NL; Kedzierska K; Pang K; Davenport MP; Chen W; Turner SJ; Doherty PC; Webby R, 2006, 'A virus-specific CD8+ T cell immunodominance hierarchy determined by antigen dose and precursor frequencies', Proceedings of the National Academy of Sciences of the United States of America, 103, pp. 994 - 999
2006
Davenport MP; Ribeiro RM; Hazenberg MD; Perelson AS, 2006, 'Naive and memory cell turnover as drivers of CCR5-to-CXCR4 tropism switch in human immunodeficiency virus type 1: implications for therapy', Journal of Virology, 80, pp. 802 - 809
2006
Davenport MP; Venturi V; Kedzierska K; Price DA; Doherty PC; Douek DC; Turner SJ, 2006, 'Sharing of T cell receptors in antigen-specific responses is driven by convergent recombination', Proceedings of the National Academy of Sciences of the United States of America, 103, pp. 18691 - 18696
2006
Davenport MP; Venturi V; Kedzierska K; Field K; Turner SJ; Doherty PC, 2006, 'Early establishment of diverse T cell receptor profiles for influenza-specific CD8(+)CD62L(hi) memory T cells', Proceedings of the National Academy of Sciences of the United States of America, 103, pp. 9184 - 9189
2006
Cromer D; Evans KJ; Schofield L; Davenport MP, 2006, 'Preferential invasion of reticulocytes during late-stage Plasmodium berghei infection accounts for reduced circulating reticulocyte levels', International Journal for Parasitology, 36, pp. 1389 - 1397
2006
Ribeiro RM; Hazenberg MD; Perelson AS; Davenport MP, 2006, 'Naïve and memory cell turnover as drivers of CCR5-to-CXCR4 tropism switch in human immunodeficiency virus type 1: Implications for therapy', Journal of Virology, 80, pp. 802 - 809, http://dx.doi.org/10.1128/JVI.80.2.802-809.2006
2006
Venturi V; Kedzierska K; Price DA; Doherty PC; Douek DC; Turner SJ; Davenport MP, 2006, 'Sharing of T cell receptors in antigen-specific responses is driven by convergent recombination', Proceedings of the National Academy of Sciences of the United States of America, 103, pp. 18691 - 18696
2006
Davenport MP; Zhang L; Shiver JW; Casmiro DR; Ribeiro RM; Perelson AS, 2006, 'Influence of peak viral load on the extent of CD4+ T-cell depletion in simian HIV infection', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 41, pp. 259 - 265
2006
Legrand FA; Abadi J; Jordan KA; Davenport MP; Deeks SG; Fennelly GJ; Wiznia AA; Nixon DF; Rosenberg MG, 2005, 'Partial treatment interruption of protease inhibitors augments HIV-specific immune responses in vertically infected pediatric patients', AIDS, 19, pp. 1575 - 1585
2005
Crough T; Burrows JM; Fazou C; Walker S; Davenport MP; Khanna R, 2005, 'Contemporaneous fluctuations in T cell responses to persistent herpes virus infections', European Journal of Immunology, 35, pp. 139 - 149
2005
Kedzierska K; La Gruta NL; Davenport MP; Turner SJ; Doherty PC, 2005, 'Contribution of T cell receptor affinity to overall avidity for virus-specific CD8+ T cell responses', Proceedings of the National Academy of Sciences of the United States of America, 102, pp. 11432 - 11437
2005
Fernandez CS; Stratov I; De Rose R; Walsh K; Dale CJ; Smith MZ; Agy MB; Hu SL; Krebs K; Watkins DI; O Connor DH; Davenport MP; Kent SJ, 2005, 'Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost', Journal of Virology, 79, pp. 5721 - 5731
2005
Wilson DP; Zhang L; Ribeiro R; Perelson AS; Davenport MP, 2005, 'Explaining mechanisms behind the virus-specific CD8+T lymphocyte response to a viral infection', Tissue Antigens, 66, pp. 590 - 591
2005
Chao DL; Davenport MP; Forrest S; Perelson AS, 2005, 'The effects of thymic selection on the range of T cell cross-reactivity', European Journal of Immunology, 35, pp. 3452 - 3459
2005
Godkin A; Davenport M; Hill AVS, 2005, 'Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine non responsiveness', HEPATOLOGY, 41, pp. 1383 - 1390, http://dx.doi.org/10.1002/hep.20716
2005
La Gruta N; Kedzierska K; Pang K; Webby R; Davenport MP; Chen W; Turner SJ; Doherty P, 2005, 'A virus specific CD8(+) T cell immunodominance hierarchy determined by precursor frequencies and antigen dose', Tissue Antigens, 66, pp. 469 - 470
2005
Fernandez C; Stratov I; De Rose R; Batten J; Smith M; Agy M; Hu SK; Krebs K; Watkins D; O Connor D; Davenport MP; Kent S, 2005, 'Control of T cell escape mutant viruses by effector T cells at transmission: Implications for the requirements of vaccine induced immunity to HIV', Tissue Antigens, 66, pp. 414 - 415
2005
Venturi V; Kedzierska K; Turner SJ; Doherty P; Davenport MP, 2005, 'High degree of sharing of T cell receptor chain sequences in `Private` T cell repertoire', Tissue Antigens, 66, pp. 578 - 578
2005
Kedzierska K; La Gruta N; Davenport MP; Turner SJ; Doherty P, 2005, 'Dissection of the high avidity clonotypes in virus-specific CD8+T cells and their dependence on `public` versus `private` nature of the TCR repertoire', Federation of American Societies for Experimantal Biology Journal, 19, pp. A401 - A402
2005
Smith MZ; Fernandez CS; Chung A; Dale CJ; De Rose R; Lin J; Brooks AG; Krebs KC; Watkins DI; O Connor DH; Davenport MP; Kent SJ, 2005, 'The pigtail macaque MHC class I allele Mane-A*10 presents an immundominant SIV Gag epitope:identification, tetramer development and implications of immune escape and reversion', Journal of Medical Primatology, 34, pp. 282 - 293
2005
Davenport MP; Zhang L; Bagchi A; Fridman A; Fu TM; Schleif W; Shiver JW; Ribeiro RM; Perelson AS, 2005, 'High-potency human immunodeficiency virus vaccination leads to delayed and reduced CD8+ T-cell expansion but improved virus control', Journal of Virology, 79, pp. 10059 - 10062
2005
Kent SJ; Fernandez CS; Dale CJ; Davenport MP, 2005, 'Reversion of immune escape HIV variants upon transmission: insights into effective viral immunity', Trends in Microbiology, 13, pp. 243 - 246, http://www.sciencedirect.com/science/article/B6TD0-4FTMM26-4/2/e8afbea904702fc224acbe284638f690
2005
Davenport MP; Ribeiro RM; Chao DL; Perelson AS, 2004, 'Predicting the impact of a nonsterilizing vaccine against human immunodeficiency virus', Journal of Virology, 78, pp. 11340 - 11351
2004
Chao DL; Davenport MP; Forrest S; Perelson AS, 2004, 'A stochastic model of cytotoxic T cell responses', Journal of Theoretical Biology, 228, pp. 227 - 240
2004
Chao DL; Davenport MP; Forrest S; Perelson AS, 2004, 'Modelling the impact of antigen kinetics on T-cell activation andresponse', Immunology and Cell Biology, 82, pp. 55 - 61
2004
Davenport MP; Ribeiro RM; Perelson AS, 2004, 'Kinetics of virus-specific CD8+ T cells and the control of human immunodeficiency virus infection', Journal of Virology, 78, pp. 10096 - 10103
2004
Zhang L; Ribeiro RM; Mascola JR; Lewis MG; Stiegler G; Katinger H; Perelson AS; Davenport MP, 2004, 'Effects of antibody on viral kinetics in simian/human immunodeficiency virus infection: implications for vaccination', Journal of Virology, 78, pp. 5520 - 5522
2004
Murray JM; Kaufmann GR; Hodgkin PD; Lewin SR; Kelleher AD; Davenport MP; Zaunders JJ, 2003, 'Naive T cells maintained by thymic output in early ages but by proliferation without phenotypic change after age twenty', Immunology and Cell Biology, 81, pp. 487 - 495
2003
GODKIN A; DAVENPORT M; THURSZ M; HILL A, 2003, '956 Molecular interactions of hepatitis B virus nucleocapsid and envelope peptides with HLA-DR1, -DR3, -DR7 and -DR13 glycoproteins', Hepatology, 38, pp. 618 - 618, http://dx.doi.org/10.1016/s0270-9139(03)80994-1
2003
Chao DL; Davenport MP; Forrest S; Perelson AS, 2003, 'Stochastic stage-structured modeling of the adaptive immune system.', Proceedings / IEEE Computer Society Bioinformatics Conference. IEEE Computer Society Bioinformatics Conference., 2, pp. 124 - 131
2003
Morrison D; FitzPatrick D; Hanson I; Williamson K; van Heyningen V; Fleck B; Jones I; Chalmers J; Campbell H, 2002, 'National study of microphthalmia, anophthalmia, and coloboma (MAC) in Scotland: investigation of genetic aetiology.', J Med Genet, 39, pp. 16 - 22, http://dx.doi.org/10.1136/jmg.39.1.16
2002
Davenport MP; Zaunders JJ; Hazenberg MD; Schuitemaker H; van Rij RP, 2002, 'Cell turnover and cell tropism in HIV-1 infection', Trends in Microbiology, 10, pp. 275 - 278
2002
Davenport MP; Fazou C; Mcmichael AJ; Callan MF, 2002, 'Clonal selection, clonal senescence, and clonal succession: the evolution of the T cell response to infection with a persistent virus', Journal of Immunology, 168, pp. 3309 - 3317
2002
Davenport MP; Ward RL; Hawkins NJ, 2002, 'The null oncogene hypothesis and protection from cancer', Journal of Medical Genetics, 39, pp. 12 - 14
2002
Davenport MP; Post JJ, 2001, 'Rapid disease and the rate of spread of the HIV epidemic', AIDS, 15, pp. 2055 - 2059
2001
Davenport MP; Post JJ, 2001, 'Rapid disease progression and the rate of spread of the HIV epidemic', AIDS, 15, pp. 2055 - 2057, http://dx.doi.org/10.1097/00002030-200110190-00024
2001
Davenport MP; Grimm MC; Lloyd AR, 2000, 'A homing selection hypothesis for T-cell trafficking', Immunology Today, 21, pp. 315 - 317
2000
Davenport MP, 2000, 'Reversibility of HIV drug resistance', Science, pp. 1299a
2000
Davenport MP, 2000, 'Benefits of memory', Nature Immunology, 1, pp. 451
2000
Davenport MP, 2000, 'Benefits of memory.', Nature immunology, 1, pp. 451
2000
Godkin AJ; Davenport MP; Willis A; Jewell DP; Hill AVS, 1998, 'Use of complete eluted peptide sequence data from HLA-DR and -DQ molecules to predict T cell epitopes, and the influence of the nonbinding terminal regions of ligands in epitope selection', Journal of Immunology, 161, pp. 850 - 858
1998
Harcourt GC; Garrard S; Davenport MP; Edwards A; Phillips RE, 1998, 'HIV-1 variation diminishes CD4 T lymphocyte recognition', Journal of Experimental Medicine, 188, pp. 1785 - 1793, http://dx.doi.org/10.1084/jem.188.10.1785
1998
Gelder C; Davenport M; Barnardo M; Bourne T; Lamb J; Askonas B; Hill A; Welsh K, 1998, 'Six unrelated HLA-DR-matched adults recognize identical CD4+ T cell epitopes from influenza A haemagglutinin that are not simply peptides with high HLA-DR binding affinities', International Immunology, 10, pp. 211 - 222, http://dx.doi.org/10.1093/intimm/10.2.211
1998
Vessey SJR; Barouch DH; McAdam SN; Tussey LG; Davenport MA; O'Callaghan CA; Bell JI; McMichael AJ; Jakobsen BK, 1997, 'Engagement of a T cell receptor by major histocompatibility complex irrespective of peptide', European Journal of Immunology, 27, pp. 879 - 885, http://dx.doi.org/10.1002/eji.1830270412
1997
Davenport MP; Smith KJ; Barouch D; Reid SW; Bodnar WM; Willis AC; Hunt DF; Hill AVS, 1997, 'HLA class I binding motifs derived from random peptide libraries differ at the COOH terminus from those of eluted peptides', Journal of Experimental Medicine, 185, pp. 367 - 371, http://dx.doi.org/10.1084/jem.185.2.367
1997
Davenport MP; Godkin A; Friede T; Stevanović S; Willis AC; Hill AVS; Rammensee HG, 1997, 'A distinctive peptide binding motif for HLA-DRB1(*)0407, an HLA-DR4 subtype not associated with rheumatoid arthritis', Immunogenetics, 45, pp. 229 - 232, http://dx.doi.org/10.1007/s002510050196
1997
Godkin A; Friede T; Davenport M; Stevanovic S; Willis A; Jewell D; Hill A; Rammensee HG, 1997, 'Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2)', International Immunology, 9, pp. 905 - 911, http://dx.doi.org/10.1093/intimm/9.6.905
1997
Davenport MP; Hill AVS, 1996, 'Reverse immunogenetics: From HLA-disease associations to vaccine candidates', Molecular Medicine Today, 2, pp. 38 - 45, http://dx.doi.org/10.1016/1357-4310(96)88757-0
1996
Davenport MP; Quinn CL; Valsasnini P; Sinigaglia F; Hill AVS; Bell JI, 1996, 'Analysis of peptide-binding motifs for two disease associated HLA-DR13 alleles using an M13 phage display library', Immunology, 88, pp. 482 - 486, http://dx.doi.org/10.1046/j.1365-2567.1996.d01-693.x
1996
Davenport MP; Smith KJ; Hill AV, 1996, 'Evolution of allorecognition?', Immunology today, 17, pp. 589 - 590, http://dx.doi.org/10.1016/S0167-5699(97)84208-9
1996
Davenport MP; Ho Shon IA; Hill AV, 1995, 'An empirical method for the prediction of T-cell epitopes', Immunogenetics, 42, pp. 392 - 397, http://www.ncbi.nlm.nih.gov/pubmed/7590973
1995
Davenport MP; Quinn CL; Chicz RM; Green BN; Willis AC; Lane WS; Bell JI; Hill AVS, 1995, 'Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DRβ chain', Proceedings of the National Academy of Sciences of the United States of America, 92, pp. 6567 - 6571
1995
Barouch D; Davenport M; Mcmichael A; Reay P, 1995, 'A mAb against HLA-A2 can be influenced both positively and negatively by the associated peptide', International Immunology, 7, pp. 1599 - 1605, http://dx.doi.org/10.1093/intimm/7.10.1599
1995
Davenport MP, 1995, 'Antagonists or altruists: do viral mutants modulate T-cell responses?', Immunology Today, 16, pp. 432 - 436, http://dx.doi.org/10.1016/0167-5699(95)80020-4
1995
Davenport MP, 1995, 'The promiscuous B27 hypothesis', The Lancet, 346, pp. 500 - 501, http://dx.doi.org/10.1016/S0140-6736(95)91348-3
1995
ROCHE PW; PEAKE PW; DAVENPORT MP; BRITTON WJ, 1994, 'Identification of a Mycobacterium leprae‐specific T cell epitope on the 70 kDa heat shock protein', Immunology and Cell Biology, 72, pp. 215 - 221, http://dx.doi.org/10.1111/j.1440-1711.1994.tb03780.x
1994
Hill AVS; Yates SNR; Allsopp CEM; Gupta S; Gilbert SC; Lalvani A; Aidoo M; Davenport M; Plebanski M, 1994, 'Human leukocyte antigens and natural selection by malaria', Philosophical Transactions of the Royal Society B: Biological Sciences, 346, pp. 379 - 383, http://dx.doi.org/10.1098/rstb.1994.0155
1994
Peake PW; Britton WJ; Davenport MP; Roche PW; McKenzie KR, 1993, 'Analysis of B-cell epitopes in the variable C-terminal region of the Mycobacterium leprae 70-kilodalton heat shock protein', Infection and Immunity, 61, pp. 135 - 141
1993
Davenport MP; McKenzie KR; Basten A; Britton WJ, 1992, 'The variable C-terminal region of the Mycobacterium leprae 70-kilodalton heat shock protein is the target for humoral immune responses', Infection and Immunity, 60, pp. 1170 - 1177
1992
Cromer D; Reynaldi A; Hie A; Schlub T; Juno J; Wheatley A; Kent S; Khoury D; Davenport M, 2024, Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updates, http://dx.doi.org/10.1101/2024.02.08.24302032
2024
Conway E; Walker C; Lydeamore M; Golding N; Ryan G; Mavec D; Oates J; Kabashima G; Price DJ; Shearer F; Cromer D; Davenport MP; McCaw J; Eriksson EM; Hodgkin PD; Wu L; Le TP; Baker CM; Mueller I; McVernon J, 2024, Optimal timing of booster doses in a highly vaccinated population with minimal natural exposure to COVID-19, http://dx.doi.org/10.1101/2024.05.14.24307386
2024
Kent SJ; Li S; Amarasena TH; Reynaldi A; Lee WS; Leeming MG; O’Connor DH; Nguyen J; Kent HE; Caruso F; Juno JA; Wheatley AK; Davenport MP; Ju Y, 2024, Blood Distribution of SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine in Humans, http://dx.doi.org/10.1101/2024.07.25.24311039
2024
Ashley CL; Bloul M; Alca S; Smith L; Jin W; Khoury D; Counoupas C; Davenport M; Triccas JA; Steain M, 2024, Optimisation of a multiplexed, high throughput assay to measure neutralising antibodies against SARS-CoV-2 variants, http://dx.doi.org/10.1101/2024.09.01.610733
2024
Berry MT; MacIntyre CR; Cromer D; Hacker A; Davenport MP; Khoury DS, 2024, Optimal deployment of limited vaccine supplies to combat mpox, http://dx.doi.org/10.1101/2024.11.03.24316551
2024
Lee WS; Tan H-X; Reynaldi A; Esterbauer R; Koutsakos M; Nguyen J; Amarasena T; Kent H; Aggarwal A; Turville S; Taiaroa G; Kinsella P; Liew KC; Tran T; Williamson D; Cromer D; Davenport M; Kent S; Juno J; Khoury D; Wheatley A, 2023, Durable reprogramming of neutralising antibody responses following breakthrough Omicron infection, http://dx.doi.org/10.1101/2023.02.19.23286159
2023
Selva KJ; Ramanathan P; Haycroft ER; Reynaldi A; Cromer D; Tan CW; Wang L-F; Wines B; Hogarth M; Downie L; Davis S; Purcell RA; Kent H; Juno J; Wheatley A; Davenport M; Kent SJ; Chung A, 2023, Lasting first impression: Pre-existing immunity restricts mucosal antibody responses during Omicron breakthrough, http://dx.doi.org/10.1101/2023.03.28.23287848
2023
Elias K; Khan S; Stadler E; Schlub T; Cromer D; Polizzotto M; Kent S; Turner T; Davenport M; Khoury D, 2023, Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: A systematic review and meta-analysis, http://dx.doi.org/10.1101/2023.06.18.23291566
2023
Wagstaffe HR; Thwaites RS; Reynaldi A; Sidhu JK; McKendry R; Ascough S; Papargyris L; Collins AM; Xu J; Lemm N-M; Siggins MK; Chain BM; Killingley B; Kalinova M; Mann A; Catchpole A; Davenport MP; Openshaw PJM; Chiu C, 2023, Mucosal and Systemic Immune Correlates of Viral Control following SARS-CoV-2 Infection Challenge in Seronegative Adults, http://dx.doi.org/10.1101/2023.07.21.23292994
2023
Berry M; Khan S; Schlub T; Notaras A; Kunasekaran M; Grulich A; MacIntyre R; Davenport M; Khoury D, 2023, Predicting vaccine effectiveness in Mpox, http://dx.doi.org/10.1101/2023.11.23.23298850
2023
Stadler E; Chai KL; Schlub T; Cromer D; Polizzotto M; Kent S; Beecher C; White H; White H; Turner T; Skoetz N; Skoetz N; Estcourt L; McQuilten Z; Wood E; Khoury D; Davenport M, 2022, Determinants of passive antibody efficacy in SARS-CoV-2 infection, http://dx.doi.org/10.1101/2022.03.21.22272672
2022
Watson NB; Patel RK; Oyesola OO; Laniewski N; Grenier JK; Wang J; Tabilas C; Yee Mon KJ; Peng SP; Wesnak SP; Nzingha K; Smith NL; Davenport MP; Tait Wojno ED; Scheible KM; Grimson A; Rudd BD, 2022, Lin28b specifies an innate-like lineage of CD8+ T cells in early life, http://dx.doi.org/10.1101/2022.02.14.480406
2022
Stadler E; Cromer D; Mehra S; Adekunle A; Flegg J; Anstey N; Watson J; Chu C; Mueller I; Robinson L; Schlub T; Davenport M; Khoury D, 2022, Risk of Plasmodium vivax recurrences follows a 30-70 rule and indicates relapse heterogeneity in the population, http://dx.doi.org/10.1101/2022.05.18.22275180
2022
Bauer A; Lindemuth E; Joy J; Marino FE; Docken SS; Krause R; Mallick S; McCormick K; Holt C; Georgiev I; Felber B; Keele BF; Veazey R; Davenport MP; Li H; Shaw GM; Bar KJ, 2022, Adaptation of a transmitted/founder simian-human immunodeficiency virus for enhanced replication in rhesus macaques, http://dx.doi.org/10.1101/2022.12.12.520031
2022
Stadler E; Cromer D; Ogunlade S; Ongoiba A; Doumbo S; Kayentao K; Traore B; Crompton P; Portugal S; Davenport M; Khoury D, 2022, A role for super-spreaders in carrying malaria parasites across the months-long dry season, http://dx.doi.org/10.1101/2022.04.28.22274398
2022
Khoury D; Schlub T; Cromer D; Steain M; Fong Y; Gilbert P; Subbarao K; Triccas J; Kent S; Davenport M, 2022, Correlates of protection, thresholds of protection, and immunobridging in SARS-CoV-2 infection, http://dx.doi.org/10.1101/2022.06.05.22275943
2022
Cromer D; Steain M; Reynaldi A; Schlub T; Sasson S; Kent S; Khoury D; Davenport MP, 2022, Neutralising antibodies predict protection from severe COVID-19, http://dx.doi.org/10.1101/2022.06.09.22275942
2022
Koutsakos M; Reynaldi A; Lee WS; Nguyen J; Amarasena T; Taiaroa G; Kinsella P; Liew KC; Tran T; Kent HE; Tan H-X; Rowntree LC; Nguyen THO; Thomas PG; Kedzierska K; Petersen J; Rossjohn J; Williamson DA; Khoury D; Davenport MP; Kent SJ; Wheatley AK; Juno JA, 2022, Rapid recall andde novoT cell responses during SARS-CoV-2 breakthrough infection, http://dx.doi.org/10.1101/2022.12.19.521129
2022
Khoury D; Docken S; Subbarao K; Kent S; Davenport M; Cromer D, 2022, Predicting the efficacy of variant-modified COVID-19 vaccine boosters, http://dx.doi.org/10.1101/2022.08.25.22279237
2022
Stadler E; Burgess M; Schlub T; Chai KL; McQuilten Z; Wood E; Polizzotto M; Kent S; Cromer D; Davenport M; Khoury D, 2022, Monoclonal antibody levels and protection from COVID-19, http://dx.doi.org/10.1101/2022.11.22.22282199
2022
Aggarwal A; Stella AO; Walker G; Akerman A; Milogiannakis V; Brilot F; Amatayakul-Chantler S; Roth N; Coppola G; Schofield P; Jackson J; Henry J; Mazigi O; Langley D; Lu Y; Forster C; McAllery S; Mathivanan V; Fichter C; Hoppe AC; Munier ML; Jack H-M; Cromer D; Darley D; Matthews G; Christ D; Khoury D; Davenport M; Rawlinson W; Kelleher A; Turville S, 2021, SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern, http://dx.doi.org/10.1101/2021.12.14.21267772
2021
Khoury D; Steain M; Triccas J; Sigal A; Davenport M; Cromer D, 2021, A meta-analysis of Early Results to predict Vaccine efficacy against Omicron, http://dx.doi.org/10.1101/2021.12.13.21267748
2021
Koutsakos M; Lee WS; Reynaldi A; Tan H-X; Gare G; Kinsella P; Liew KC; Williamson D; Kent H; Stadler E; Cromer D; Khoury D; Wheatley A; Juno J; Davenport M; Kent S, 2021, Dynamics of immune recall following SARS-CoV-2 vaccination or breakthrough infection, http://dx.doi.org/10.1101/2021.12.23.21268285
2021
Goel RR; Painter MM; Apostolidis SA; Mathew D; Meng W; Rosenfeld AM; Lundgreen KA; Reynaldi A; Khoury DS; Pattekar A; Gouma S; Kuri-Cervantes L; Hicks P; Dysinger S; Hicks A; Sharma H; Herring S; Korte S; Baxter AE; Oldridge DA; Giles JR; Weirick ME; McAllister CM; Awofolaju M; Tanenbaum N; Drapeau EM; Dougherty J; Long S; D'Andrea K; Hamilton JT; McLaughlin M; Williams JC; Adamski S; Kuthuru O; UPenn COVID Processing Unit ; Frank I; Betts MR; Vella LA; Grifoni A; Weiskopf D; Sette A; Hensley SE; Davenport MP; Bates P; Luning Prak ET; Greenplate AR; Wherry EJ, 2021, mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern., http://dx.doi.org/10.1101/2021.08.23.457229
2021
Moriarty RV; Fesser N; Sutton MS; Venturi V; Davenport MP; Schlub T; O'Connor SL, 2021, Validation of multiplex PCR sequencing assay of SIV, http://dx.doi.org/10.21203/rs.3.rs-35062/v2
2021
Lansink LIM; Engel JA; Lee HJ; Soon MSF; Williams CG; SheelaNair A; Pernold CPS; Laohamonthonkul P; Akter J; Stoll T; Hill MM; Talman AM; Russell A; Lawniczak M; Davenport MP; Khoury DS; Haque A, 2021, Systemic host inflammation induces stage-specific transcriptomic modification and slower maturation in malaria parasites, http://dx.doi.org/10.1101/2021.08.18.456784
2021
Juno JA; Tan H-X; Lee WS; Reynaldi A; Kelly HG; Wragg K; Esterbauer R; Kent HE; Batten CJ; Mordant FL; Gherardin NA; Pymm P; Dietrich MH; Scott NE; Tham W-H; Godfrey DI; Subbarao K; Davenport MP; Kent SJ; Wheatley AK, 2020, Immunogenic profile of SARS-CoV-2 spike in individuals recovered from COVID-19, http://dx.doi.org/10.1101/2020.05.17.20104869
2020
Lee WS; Selva KJ; Davis S; Wines B; Reynaldi A; Esterbauer R; Kelly H; Haycroft E; Tan H-X; Juno J; Wheatley A; Hogarth M; Cromer D; Davenport M; Chung A; Kent S, 2020, Decay of Fc-dependent antibody functions after mild to moderate COVID-19, http://dx.doi.org/10.1101/2020.12.13.20248143
2020
Wheatley A; Juno J; Wang J; Selva K; Reynaldi A; Tan H-X; Shi Lee W; Wragg K; Kelly H; Esterbauer R; Davis S; Kent H; Mordant F; Schlub T; Gordon D; Khoury D; Subbarao K; Cromer D; Gordon T; Chung A; Davenport M; Kent S, 2020, Evolution of immunity to SARS-CoV-2, http://dx.doi.org/10.1101/2020.09.09.20191205
2020
Moriarty RV; Fesser N; Sutton MS; Venturi V; Davenport MP; Schlub T; O'Connor SL, 2020, Validation of multiplex PCR sequencing assay of SIV, http://dx.doi.org/10.21203/rs.3.rs-35062/v1
2020
Soon M; Lee HJ; Engel J; Straube J; Thomas B; Clarke L; Laohamonthonkul P; Pernold C; Haldar R; Williams C; Lansink L; Koufariotis R; Lakis V; Wood S; Chen X; James K; Lönnberg T; Lane S; Davenport M; Khoury D; Svensson V; Teichmann S; Haque A, 2019, Transcriptome Dynamics Reveals Progressive Transition from Effector to Memory in CD4+T cells, http://dx.doi.org/10.1101/675967
2019
Aliota MT; Dudley DM; Newman CM; Weger-Lucarelli J; Stewart LM; Koenig MR; Breitbach ME; Weiler AM; Semler MR; Barry GL; Zarbock KR; Mohns MS; Mohr EL; Venturi V; Schultz-Darken N; Peterson E; Newton W; Schotzko ML; Simmons HA; Mejia A; Hayes JM; Capuano S; Davenport MP; Friedrich TC; Ebel GD; O’Connor SL; O’Connor DH, 2017, Molecularly barcoded Zika virus libraries to probein vivoevolutionary dynamics, http://dx.doi.org/10.1101/221564
2017
Cao P; Klonis N; Zaloumis S; Khoury DS; Cromer D; Davenport MP; Tilley L; Simpson JA; McCaw JM, 2017, A mechanistic model quantifies artemisinin-induced parasite growth retardation in blood-stage Plasmodium falciparum infection, http://dx.doi.org/10.48550/arxiv.1701.05302
2017
Koutsakos M; Reynaldi A; Lee WS; Nguyen J; Amarasena T; Taiaroa G; Kinsella P; Liew KC; Tran T; Kent H; Tan H-X; Rowntree LC; Nguyen THO; Thomas P; Kedzierska K; Petersen J; Rossjohn J; Williamson D; Khoury D; Davenport M; Kent SJ; Wheatley AK; Juno JA, Rapid Recall and <i>de novo</i> T Cell Responses During SARS-CoV-2 Breakthrough Infection, http://dx.doi.org/10.2139/ssrn.4311124
Lau JSY; Cromer D; Pinkevych M; Lewin SR; Rasmussen TA; McMahon JH; Davenport MP, 2022, 'Balancing Statistical Power and Risk in HIV Cure Clinical Trial Design', in Journal of Infectious Diseases, pp. 236 - 245, http://dx.doi.org/10.1093/infdis/jiac032
2022
Statzu M; Wong A; McBrien J; Choe Y; Enemuo C; Ngo J; Jimenez L; Wang J; Pinkevych M; Docken S; Davenport M; Keele B; Vanderford T; Paiardini M; Silvestri G; Kulpa D, 2022, 'CD8(+) T cell depletion does not affect viral reservoir size, but influences the rebound after ART interruption in SIV-infected rhesus macaques', in JOURNAL OF MEDICAL PRIMATOLOGY, WILEY, pp. 323 - 324, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000852720100075&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2022
Okoye A; Duell D; Maxwel A; Brantley W; Marenco A; Lidell M; Behrens H; Selseth A; Varco-Merth B; Smedley J; Hesselgesser J; Geleziunas R; Pinkevych M; Davenport M; Axthelm M; Hansen S; Deeks S; Keele B; Lifson J; Picker L, 2018, 'CD8+T Cells Do Not Control SIV Replication During ART or Viral Relapse After ART Withdrawal', in AIDS RESEARCH AND HUMAN RETROVIRUSES, MARY ANN LIEBERT, INC, SPAIN, Madrid, pp. 33 - 33, presented at HIV Research for Prevention Meeting (HIVR4P) - AIDS Vaccine, Microbicide and ARV-Based Prevention Science, SPAIN, Madrid, 21 October 2018 - 25 October 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000448371600042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Davenport MP; Valkenburg S; Guillonneau C; Hubert F-X; Cukalac T; Curtis JM; Stambas J; Scott H; Venturi V; Kedzierski L; Kedzierska K, 2009, 'The absence of Aire does not alter the CD8 T cell repertoire to infection', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209763601194&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
RIBEIRO RM; PERELSON AS; CHAO DL; DAVENPORT MP, 2007, 'HIV EPIDEMIOLOGY AND THE IMPACT OF NONSTERILIZING VACCINES', in BIOMAT 2006, WORLD SCIENTIFIC, pp. 69 - 88, presented at International Symposium on Mathematical and Computational Biology, http://dx.doi.org/10.1142/9789812708779_0005
2007
Goel RR; Painter MM; Lundgreen KA; Apostolidis SA; Baxter AE; Giles JR; Mathew D; Pattekar A; Reynaldi A; Khoury DS; Gouma S; Hicks P; Dysinger S; Hicks A; Sharma H; Herring S; Korte S; Kc W; Oldridge DA; Erickson RI; Weirick ME; McAllister CM; Awofolaju M; Tanenbaum N; Dougherty J; Long S; D'Andrea K; Hamilton JT; McLaughlin M; Williams JC; Adamski S; Kuthuru O; Drapeau EM; Davenport MP; Hensley SE; Bates P; Greenplate AR; Wherry EJ, 2022, Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine., http://dx.doi.org10.1101/2022.02.20.481163, https://www.ncbi.nlm.nih.gov/pubmed/35233575
2022
Cele S; Jackson L; Khoury DS; Khan K; Moyo-Gwete T; Tegally H; San JE; Cromer D; Scheepers C; Amoako D; Karim F; Bernstein M; Lustig G; Archary D; Smith M; Ganga Y; Jule Z; Reedoy K; Hwa S-H; Giandhari J; Blackburn JM; Gosnell BI; Abdool Karim SS; Hanekom W; NGS-SA ; COMMIT-KZN Team ; von Gottberg A; Bhiman J; Lessells RJ; Moosa M-YS; Davenport MP; de Oliveira T; Moore PL; Sigal A, 2021, SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection., http://dx.doi.org10.1101/2021.12.08.21267417, https://www.ncbi.nlm.nih.gov/pubmed/34909788
2021
Charon J; Grigg M; Eden J-S; Piera K; William T; Rose K; Davenport M; Anstey N; Holmes E, 2019, Matryoshka RNA virus 1: a novel RNA virus associated with Plasmodium parasites in human malaria, http://dx.doi.org10.1101/624403
2019
Docken S; McCormick K; Pampena M; Pinkevych M; Viox E; Keele B; Paiardini M; Betts M; Bar K; Davenport M; Samer S; Cromer D; Schlub T, 2022, 'PP 2.3 – 00034 CD8+ T-Cell Sieving During SIV Reactivation from Latency', Vol. 8, pp. 100159 - 100159, http://dx.doi.org/10.1016/j.jve.2022.100159
2022
Varco-Merth B; Chaunzwa M; Duell D; Marenco A; Docken S; Smedley J; Axthelm MK; Hansen SG; Davenport MP; Estes JD; Keele B; Lifson JD; Lewin SR; Okoye AA; Picker LJ, 2022, 'OP 2.5 – 00048 Targeting the SIV reservoir with Alemtuzumab', Vol. 8, pp. 100153 - 100153, http://dx.doi.org/10.1016/j.jve.2022.100153
2022
Viox E; Samer S; Nguyen K; Docken S; Lindemuth E; Mampe F; Pinkevych M; Keele B; Betts M; Davenport M; Paiardini M; Bar K, 2022, 'Impact of CD4 binding-site bNAb therapy on viral rebound in barcoded TF-SHIV-D-infected rhesus macaques at ATI', in JOURNAL OF MEDICAL PRIMATOLOGY, WILEY, Vol. 51, pp. 301 - 302, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000852720100028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2022
Keele B; Okoye A; Immonen T; Pinkevych M; Fennessey C; Varco-Merth B; Davenport M; Lifson J; Picker L, 2022, 'Early antiretroviral therapy in SIV-infected rhesus macaques reveals a highly dynamic accumulation of the rebound competent viral reservoir', in JOURNAL OF MEDICAL PRIMATOLOGY, WILEY, Vol. 51, pp. 303 - 303, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000852720100032&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2022
Pampena MB; Kuri-Cervantes L; Samer S; Wu V; Watkins M; Veazey R; Bar K; Keele B; Davenport M; Paiardini M; Betts M, 2022, 'Enforced lymphoid tissue retention of CD8(+) T cells in SIV-infected Rhesus Macaques does not induce control of SIV plasma viremia', in JOURNAL OF MEDICAL PRIMATOLOGY, WILEY, Vol. 51, pp. 318 - 318, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000852720100064&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2022
Lansink LIM; Engel JA; Lee HJ; Soon MSF; Williams CG; Aogo RA; Cromer D; Davenport MP; Khoury DS; Haque A, 2021, 'Exposure to host inflammation in vivo induces rapid transcriptomic change and impaired maturation in malaria parasites', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, Vol. 206, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000713665801305&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2021
Tabilas C; Reynaldi A; Daly CWP; Mon KY; Wesnak S; Smith NL; Davenport MP; Grimson AW; Rudd BD, 2021, 'Microbial exposure in early life alters the ontogeny and function of CD8+T cells', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, Vol. 206, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000713665801448&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2021
Okoye AA; Duell DM; Marenco A; Lidell M; Behrens H; Selseth A; Varco-Merth B; Hesselgesser J; Geleziunas R; Smedley J; Park H; Axthelm MK; Davenport M; Hansen SG; Deeks SG; Keele B; Lifson JD; Picker LJ, 2020, 'CD8+T cells provide limited control of SIV reactivation after combination antiretroviral therapy (cART) cessation', in JOURNAL OF MEDICAL PRIMATOLOGY, WILEY, Vol. 49, pp. 238 - 239, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000571653100042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2020
Pino M; King C; Shim I; Wang H; Nguyen K; Samer S; Harper J; Lifson J; Reynaldi A; Deleage C; Padhan K; Cervasi B; Davenport MP; Petrovas C; Lederman MM; Paiardini M, 2019, 'Fingolimod treatment at ART initiation delays SIV rebound after ART interruption', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 22, pp. 43 - 43, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000476890500090&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Fennessey C; Pinkevych M; Immonen T; Camus C; Del Prete G; Estes J; Lifson J; Davenport M; Keele B, 2017, 'Assessing individual viral reactivations of the latent reservoir using a novel barcoded virus', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 20, pp. 1 - 1, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000406429800002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2017
Pinkevych M; Reynaldi A; Fennessey C; Reid C; Nadella P; Lipkey L; Newman L; Ayala V; Jain S; Del Prete G; Estes J; Ott D; Lifson J; Ohlen C; Keele B; Davenport M, 2016, 'Frequent and "burst-like'' reactivation from latency in SIVmac239M infected macaques', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 19, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000395394300134&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2016
Hill AVS; Yates SNR; Allsopp CEM; Gupta S; Gilbert SC; Lalvani A; Aidoo M; Davenport M; Plebanski M, 1997, 'Human leukocyte antigens and natural selection by malaria', in Infection, Polymorphism and Evolution, Springer Netherlands, pp. 109 - 115, http://dx.doi.org/10.1007/978-94-009-0077-6_12
1997
Davenport MP; Hill AVS, 1996, 'The MHC in Host-Pathogen Evolution', in MHC Molecules: Expression, Assembly and Function, Springer US, pp. 243 - 260, http://dx.doi.org/10.1007/978-1-4684-6462-7_15
1996

The Infection Analytics Program uses mathematical, statistical and computational approaches to investigate treatment and immunity to infectious diseases. The major focuses of the team are on HIV immunity and latency, antimalarial treatment and immunity, and neonatal immunity. The team collaborates with around 30 experimental and clinical groups worldwide to use modelling to understand the dynamics of infection and immunity.

Immunology, Infectious Diseases, HIV - AIDS, Biostatistics, Virology, parasitology, COVID-19